As global awareness of environmental issues grows, businesses are increasingly confronted with the dual challenge of achieving their sustainability goals while ensuring compliance with an ever-evolving regulatory landscape. One sector in which this is felt acutely is personal protective equipment (PPE) so how do you reduce environmental impact and maintain product efficacy?  Regulatory compliance, sustainability and stakeholder demands  In many industries, sustainability and regulatory compliance are often viewed as two sides of the same coin. While regulatory compliance serves as a foundational requirement for businesses, sustainability is increasingly becoming a competitive differentiator. Guido Van Duren, Ansell’s Director of Global Regulatory…

Pfizer announced that the National Institute for Health and Care Excellence (NICE) has published final draft guidance which recommends Hympavzi (marstacimab) as an option for preventing bleeding episodes in people 12 years of age and older, weighing at least 35 kg, with severe haemophilia B (congenital factor IX deficiency, factor 9 activity less than 1%), without factor 9 inhibitors (anti-factor antibodies). Discovered and developed by Pfizer scientists, marstacimab is the first once-weekly subcutaneous treatment administered via a pre-filled pen for severe haemophilia B to be routinely available on the NHS. It targets the Kunitz 2 domain of tissue factor pathway inhibitor…

Ellie Gabel, associate editor, Revolutionized explores how it has been a turbulent few years for pharmaceutical supply chains. Just as things were returning to normal after the COVID-19 pandemic, geopolitical instability reared its head. How will the trade war impact drugmakers? Can industry professionals prepare for the unpredictable volley of policy changes? Discover how geopolitical uncertainties are affecting supply chains in the pharmaceutical sector. Recent policy changes add to geopolitical instability  President Trump’s “reciprocal” tariffs initially exempted drug products. However, in April, President Trump threatened the sector with a major, targeted tax similar to the 25% levied on steel, aluminium…

Qubit Pharmaceuticals, a deeptech company specialising in the discovery of new drug candidates, unveils the “world’s most advanced” quantum AI model to unlock an entirely new range of therapeutics. The quantum AI model, developed in partnership with Sorbonne University, is capable of modelling and simulating the behaviour of molecules with a level of precision and computational speed never before achieved. The accuracy will massively reduce the costly stage of laboratory experimentation in the development of new molecules by replacing the chemical synthesis of drug candidates. “This simulation method would reduce the cost of the drug discovery phase enormously,” said Jean-Philip Piquemal,…

In order to limit the devastating effects of global warming and climate change, the UK has legally committed to reaching net zero by 2050, meaning that greenhouse gas (GHG) emissions will be equal to the emissions removed from the atmosphere. Etienne Fourie, technical sales manager, Babcock Wanson discusses. Industry is responsible for 13.7% of GHG emissions in the UK and, whilst strides have been made to reduce emissions, with 50% of industrial energy consumption still provided by fossil fuels, there’s a long way to go. The UK government’s Review of Energy Policy 2024 acknowledges that a comprehensive industrial strategy needs to…

The pharmaceutical and medtech divisions of IMA Group have introduced the All-In-One supplier, specialised in the design and manufacture of machines and complete lines for the packaging and processing of pharmaceutical and medical products, as well as projects concerning digitalisation, sustainability, and customer service solutions.  Meeting the Divisions at the PHARMINTECH:  IMA Active: advanced capsule filling and beyond   IMA Active will be presenting ADAPTA 50, a capsule filling machine designed for maximum flexibility and precision. This highly versatile solution, available in multiple configurations, is engineered to handle complex product combinations in hard gelatine capsules, as well as the micro-dosing of powders…

Best Formulations, a Sirio Pharma Company (Sirio), a nutraceutical contract development and manufacturing organisation (CDMO), has successfully completed its National Sanitation Foundation (NSF) recertification audit, securing an ‘A’ rating for the sixth consecutive year. This achievement underscores Sirio’s unwavering organisation-wide commitment to quality, compliance and operational excellence, ensuring customers receive the highest standard of nutraceutical products.  The NSF 455-2 audit is a rigorous current Good Manufacturing Practice (cGMP) assessment incorporating the 21 CFR Part 111 Dietary Supplement Compliance Guide requirements, along with recognised industry best practices. Administered by NSF, a globally recognised organisation dedicated to public health and safety, the…

Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania. The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecules, providing comprehensive technical support to biopharmaceutical companies and contract manufacturers operating from small-scale to full commercial production. This new development location is well positioned in the Eastern U.S., close to many large pharmaceutical operations and a hub of bioprocessing innovation. The lab is equipped with high-throughput process development tools and manufacturing scale chromatography columns, enabling biotech firms to receive turnkey support for process…

Honeywell has introduced TrackWise Recall Management, a cloud-based artificial intelligence (AI)-assisted platform that redefines how life sciences manufacturers proactively manage product recalls in order to improve patient safety and minimise business impact of these events.   In the first quarter of 2024, medical device and pharmaceutical recalls increased by 13.8% quarter-over-quarter to 296 recalls, impacting countless patients who rely on high quality, life-saving products daily. These recall events can cause financial and reputational implications for life sciences companies if not solved in a timely manner. To help manufacturers effectively navigate recalls, TrackWise Recall Management is designed to enable organisations to quickly address…

Fette Compacting and CMIC CMO USA, a Contract Development and Manufacturing Organisation (CDMO), are entering into a strategic cooperation. The partnership marks a milestone in the implementation of Fette Compacting’s new strategy “Together – from lab to production” and strengthens the company’s position as a holistic process partner. At the center of the collaboration is the integration of the FE CPS Continuous Direct Compression system with a FE55 rotary tablet press from Fette Compacting into CMIC’s GMP-certified cleanrooms in Cranbury, New Jersey. With the help of Fette Compacting and CMIC, pharmaceutical companies can develop and validate Continuous Manufacturing processes and…

Rainer Semmler, head of process safety management, TÜV SÜD Industrie Service and Hermann Schubert, head of digital and continuous Inspection, TÜV SÜD Industrie Service explains how in pharmaceutical manufacturing, both sterility and uninterrupted operations are essential – this poses challenges when it comes to component monitoring. Acoustic Emission Testing (AT) offers a non-invasive way to assess system integrity without halting production or breaching cleanroom conditions. Moreover, the use of AT improves safety verification while enhancing system uptime. TÜV SÜD illustrates how this method works and how plant operators in pharma can use it to achieve considerable savings without neglecting compliance…

Aptamer Group, the developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17th May 2025).   Developed through an internal research programme and in collaboration with AstraZeneca, the Optimer system is based on next-generation synthetic oligonucleotide ligands designed to achieve tissue-specific targeting. The latest findings show that the Optimer construct selectively targets fibrotic tissue across multiple organ systems—including liver, kidney, skin, lung, and heart—and is compatible with both mouse and…

Data in life sciences is more than a mere byproduct of research; it is a driving force behind innovation. Rohit Dayama, global client partner, Life Sciences, UK&I, Cognizant explores how by harnessing extensive datasets, organisations can speed up drug discovery, refine precision medicine, and improve operational efficiency. This shift has transformed data management into an essential cornerstone rather than just a technical tool. Although artificial intelligence (AI) continues to captivate the industry, the true cornerstone of successful digital initiatives lies in mastering data control.   Yet, without proper oversight, the risks are substantial. For instance, the EU’s AI Act imposes severe penalties…

Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the critical need for rapid and automated plasmid DNA isolation, enabling scientists to conduct small-scale experiments quickly and affordably.   Purifying plasmid DNA, essential for researching therapeutics for diseases such as infectious diseases, cancers, and monogenic disorders, can now be done more efficiently.   Exceptional for workflows requiring high-quality plasmid DNA, the MagMAX Pro HT NoSpin Kit is one of the fastest plasmid purification kits available. From just 1 millilitre of fresh sample culture, this innovative approach allows for 96 minipreps to be completed in…

N4 Pharma, the UK biotech developing Nuvec, its proprietary gene delivery system to enable advanced therapies for cancer and other diseases, has announced positive results from its first in vivo study evaluating the use of its Nuvec proof-of-concept programme, N4 101, an orally delivered anti-inflammatory treatment for Inflammatory Bowel Disease (IBD).  Following the successful completion of in vitro profiling in December 2024, N4 Pharma has now completed its first in vivo study using an industry-standard mouse model of IBD. The study explored the therapeutic potential of orally administered Nuvec particles loaded with siRNA alone and combined with mRNA.  Over a nine-day dosing period, mice…

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has revealed the keynote speakers for its event, Drug Discovery 2025. Taking place at the ACC in Liverpool, UK from 21–22nd October, the conference will feature presentations from Professor Heather Pinkett (Northwestern University) and Dr Dafydd Owen (Pfizer Medicine Design). Held under the theme “A Festival of Life Science”, Drug Discovery 2025 is a celebration that aims to unite scientists from industry and academia working toward the same goal: improving human health through more effective drug discovery. The event offers free access to over 150 talks across 14…

James Kennedy, technology analyst at IDTechEx, explores how the global shift away from fossil-based systems is driving momentum for the bioeconomy as a more sustainable and circular alternative. This emerging economic model centres around the use of renewable biological resources sourced from agriculture, forestry, fisheries, and aquaculture to produce a broad range of products, including food, feed, materials, chemicals, and bioenergy. In its new report, “White Biotechnology 2025-2035: Technologies, Forecasts, Markets, Players“, IDTechEx provides a comprehensive and independent analysis of this transition. The report maps the technological landscape, evaluates key market developments, and identifies long-term commercial opportunities in industrial biomanufacturing.…

Southgate Global has invested in enhancing its Mobile Powered Workstation (MPW) which can boost dock-to-stock times and give companies a performance edge.  In today’s challenging economic climate, where operational efficiency is critical to success in the pharma supply chain, Southgate Global believes that empowering the human element is essential. With stringent regulatory requirements to the need for cold chain management, the pharmaceutical supply chain demands innovation.  As the speed of the supply chain continues to ramp up, customers are looking for efficient suppliers.   Speeding up processes and reducing dock-to-stock time, which is the time it takes to put goods that arrive…

Scotland’s life sciences sector is a crucial part of the nation’s economy, contributing innovation in areas such as biotechnology, pharmaceuticals, and vaccine manufacture. Jeanette Rigby, director human resources at Valneva Scotland, discusses. Recent data shows the sector now contributes almost £10.5bn to the Scottish economy, with life sciences exports worth £4.3bn, and the potential is building. Its strong academic foundation, coupled with a robust talent pool and the Scottish Government’s life sciences strategy, makes Scotland a prime destination for innovation and investment. However, if we are to remain competitive globally, Scottish companies must invest in their people. This is an…

Tjoapack, a global contract packaging organization, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.  The new tool enhances efficiency and transparency in artwork management, file exchange, workflow creation, and order management, reinforcing Tjoapack’s commitment to providing seamless, customer-centric solutions. The launch also marks an expanded partnership with Veratrak, a leading provider of SaaS solutions purpose-built for the life sciences industry. Veratrak works with 200+ partners over 6 continents providing innovative software solutions designed to improve transparency, efficiency, and security across the pharmaceutical supply chain. The firms…

NewBiologix has announced it has granted a non-exclusive technology license to ReciBioPharm, Recipharm’s Advanced Therapies (ATMP) division and a Contract Development and Manufacturing Organisation (CDMO), to provide global biotech and pharma companies with access to NewBiologix’s Xcell-Eng-HEK293 cell lines. The Xcell-Eng-HEK293 cell lines are high-value solutions for manufacturing recombinant adeno-associated viruses (rAAV) for use in C&GT. NewBiologix provides cGMP-ready, high-yield, viral particle-producing cell lines and manufacturing technologies for developing gene therapies. This unique cell line enables customers to speed up development and quickly advance C&GT programs to clinical trials. NewBiologix uses advanced technologies combining multidimensional digital PCR with third-generation sequencing. Its tightly controlled cell line coupled with…

Formosa Pharmaceuticals and Almac Discovery announce a global licensing agreement for development and commercialisation of ALM-401. The agreement facilitates the next phases of CMC and drug development by Formosa, including IND submission and early clinical proof-of-concept in international clinical trials.  ALM-401 has been the culmination of a multi-year R&D programme at Almac Discovery deploying their proprietary OmniaScape informatics platform, protein engineering and medicinal chemistry capabilities.   The design of ALM-401 has built upon the recent clinical successes within the ADC field, including selection of a linker-payload matched to potential clinical cancer indications, and the molecule also benefits from being approximately half the…

Isarna Therapeutics presented final positive results from its Phase II BETTER trial at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting on 6th May. Isarna’s chief medical officer, Prof. Marion R. Munk, shared data on ISTH0036, a selective TGF-β2-blocking antisense oligonucleotide, in patients with wet age-related macular degeneration (nAMD) and diabetic macular edema (DME). The study evaluated the potential of ISTH0036 to address retinal fibrosis, an unmet medical need not targeted by current anti-VEGF therapies. In the international multicentre study, patients who received intravitreal injections of ISTH0036 every eight weeks (Q8W) experienced stable or improved best-corrected visual acuity (BCVA),…

DFE Pharma has achieved the ISO 22301 certification for Business Continuity Management Systems (BCMS) at its head office at Goch, Germany.  This certification demonstrates DFE Pharma’s commitment to ensuring that its critical business functions and infrastructure are prepared to safeguard operations and maintain consistent excipient availability. The ISO 22301 certification is awarded following a rigorous, independent, third-party assessment that evaluates a company’s ability to maintain operations and deliver products and services to its customers in the event of any possible contingencies. DFE Pharma has successfully completed this auditing process, proving its robust preparedness for responding to disruptions and sustaining operations continuity during…

For centuries, the way we publish and evaluate scientific research has remained largely unchanged. Researchers submit their work to journals, wait months, sometimes even years, for peer review and often face significant paywalls and accessibility challenges. However, the growing movement of decentralised science (DeSci) is challenging this outdated model. Philipp Koellinger, CEO and co-founder of open science pioneer DeSci Labs, explains this reshaping of the scientific publishing landscape and explores what it means for scientists worldwide.  Scientific publishing is meant to facilitate the open exchange of knowledge and advance scientific discovery. However, the current system often does the opposite.  Researchers…

ProBioGen has announced an agreement with Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars. Under this agreement ProBioGen will conduct high-performance cell line development services for Polpharma’s biosimilar candidate, supporting their expanding pipeline. The biologics industry mantra ‘the process defines the product,’ underscores the importance of starting with the right cell line. Leveraging its cell line development platform, CHO.RiGHT, including the proprietary DirectedLuck transposase technology and decades of expertise in cell line development for new biological entities and biosimilars, ProBioGen will generate a robust, high-yielding production cell line that meets the critical quality attribute profile of Polpharma’s biosimilar. This collaboration…

For manufacturers facing production challenges, renting product inspection systems can be a cost-effective, flexible solution. Christine Gottschalk, head of PI Test and Demo Center at Mettler-Toledo, discusses the benefits of rental technologies, including bridging delivery gaps, scaling up without CAPEX and how to achieve the best product quality with advanced inspection solutions.  Why should manufacturers consider renting product inspection systems instead of purchasing them outright?  Renting our systems i.e. checkweighing, metal detection, x-ray and/or vision inspection, offers a flexible and cost-effective solution for manufacturers facing immediate product inspection needs. This can be due to increased demand, equipment breakdown or quality…

Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organisation (CDMO), has announced it has licensed ATUM’s proprietary Leap-In Transposase transposon-based gene delivery and its miCHO cell line development technologies. ATUM’s Leap-In Transposase technology can achieve “high levels of gene integration”, resulting in a large number of cells with the desired gene insertion, “precise” integration as a single copy into the host cell’s genome, and integration into multiple locations within the genome, reducing the risk of gene silencing or other adverse effects. When used in a cell line development program, Leap-In Transposase technology delivers productive, stable, and robust cell…

Antares Vision Group, has expanded its solutions portfolio to include precision labelling equipment, through a partnership with Italy-based Siempharma. At INTERPHEX NYC in early April, Antares Vision Group debuted the ETF-300 Labeling Machine, suitable for the high-speed, automatic labelling of pharmaceutical jars, bottles and other cylindrical containers.   The ETF-300 can handle containers from 40-180mm in height, and 22-80mm in diameter. It can apply labels as tall as 100mm at speeds of up to 80 meters per minute. To maximise machine uptime, the unit can switch efficiently between various container and label sizes, with changeover taking only 15-30 minutes.   Configured to meet…

Astraveus, the benchtop cell factory company, has announced that it has entered into a strategic partnership with The Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen) to evaluate The Lakhesys Benchtop Cell Factory for the manufacturing of CAR-T therapies. Under the terms of the agreement, NecstGen will utilise Astraveus’ unique Lakhesys Benchtop Cell Factory at its facility in Leiden, to demonstrate its potential to significantly reduce costs and increase efficiency in CAR-T manufacturing in comparison to incumbent industry benchmarks. Additionally, NecstGen will produce Lentiviral vectors for Astraveus’ internal research and development needs. Astraveus recently demonstrated the potential of its…

Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) met all primary endpoints, demonstrating a “clinically meaningful improvement” in lung function compared with dual-combination inhaled corticosteroid/long-acting beta2-agonist (ICS/LABA) medicines. KALOS and LOGOS were replicate, randomised, double-blind trials designed to investigate Breztri as a potential treatment for asthma. The trials evaluated the efficacy and safety of Breztri versus maintenance treatment with ICS/LABA in adults and adolescents with uncontrolled asthma. Asthma is a common, chronic respiratory disease characterised by inflammation and muscle tightening in the airway (bronchoconstriction), which can…

4titude PCR plates from Azenta Life Sciences are “optimised” to meet the varied and often overlooked needs of modern PCR workflows. Manufactured from virgin polypropylene in a Class 7 ISO-certified cleanroom, these 96- and 384-well plates are available in both low- and high-profile formats, with options for non-skirted, semi-skirted, and fully skirted designs. The ultra-thin-walled construction ensures efficient heat transfer, a critical factor in achieving consistent amplification, while raised rims support reliable sealing—helping to avoid sample loss or contamination. It is widely acknowledged that well colour influences performance in real-time applications. While clear wells provide excellent visibility for pipetting and sample inspection, they can fall short when…

Bürkert has released a new pinch valve for use in single-use biopharma applications. The new Type 2707 Pinch Valve ensures process safety and reliability with a stainless steel locking and pinch mechanism that optimises flow while protecting the tube insertion. The versatile valve, available in modulating control and on/off versions, is compatible with a range of tube diameters, and is fast and simple to fit. Bürkert’s new Type 2707 Pinch Valve is externally controlled and includes a choice of pneumatic actuator and an interchangeable tube holder. With the Element actuator for modulating control, the valve is suitable for applications such as…

Amerikooler highlights its XPS Insulation, engineered to deliver “unparalleled” thermal performance, durability, and environmental responsibility across a wide range of applications. This advanced insulation solution is specifically designed to meet the evolving demands of the commercial refrigeration industry, providing key benefits that enhance energy efficiency and promote sustainability.  Amerikooler’s XPS Insulation is manufactured with a 100% void free closed cell structure, ensuring consistent insulation performance and preventing air and moisture penetration, which protects against damage from harsh environmental conditions. Its ultra uniform foam density delivers a consistent R-value throughout the insulation, guaranteeing optimal thermal protection. With a continuous and consistent R-value…

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva to provide customers with an integrated offering for optimised biologics production. The new offering will provide seamless access to Asimov’s CHO Edge cell line development platform, Cytiva’s HyClone media and feed solutions, and Cytiva’s Fast Trak process development services. Together, these services and technologies enable the expression and development of protein biologics, including complex modalities, that hold the potential to significantly impact human health.  Alec Nielsen, co-founder and CEO of Asimov, said: “Central to this collaboration is the extensive optimisation of our CHO Edge…

NETZSCH Pumps & Systems announces the NEMO R. MY Magnetically Coupled Pump, a pump designed to meet the most demanding requirements of industries requiring leak-free pumping solutions.  While mechanical seals are widely used and are a proven method of preventing leakage in pump systems, the failure of a mechanical seal system leads to a seal leak. The NEMO R. MY Magnetically Coupled Pump features a hermetically sealed design, eliminating the risk of leakage. The pump utilises a magnetic coupling to transmit torque, ensuring a completely sealed and robust system. This design enhances safety and reliability, making it ideal for handling aggressive, toxic, or abrasive…

Lineage Cell Therapeutics, a clinical-stage biotechnology company, has announced that the Company has initiated the DOSED (Delivery of Oligodendrocyte Progenitor Cells (OPCs) for Spinal Cord Injury: Evaluation of a Novel Device) clinical study. The DOSED study will evaluate the safety and utility of the Manual Inject Parenchymal Spinal Delivery System (MI PSD System), a novel delivery device developed to deliver OPC1 directly to the area of injury in patients with spinal cord injury (SCI). OPC1 is an investigational, allogeneic stem cell-derived cell transplant, comprised of oligodendrocyte progenitor and related glial cells. OPC1 is designed to replace or support cells in the spinal cord that are absent or…

Cold Chain Technologies (CCT) launches a curbside recyclable parcel shipper portfolio. The CCT TRUEtemp Naturals shipper is a truly curbside recyclable, universal solution that combines robust thermal performance, operational efficiency and cost-effectiveness, all while reinforcing CCT’s commitment to sustainability and innovation in cold chain logistics.  The new product is designed for first-mile, parcel-sized shipments, ensuring temperature-sensitive products stay thermally protected while offering an eco-conscious alternative to traditional packaging. Whether shipping goods from local distribution centres to stores or from manufacturers to distribution hubs, this shipper delivers both performance and sustainability.   Qualified for ISTA 7E RFG profile, the TRUEtemp Naturals Shipper ensures reliable…

Niklas Adamsson, chief operating officer at Envirotainer discusses why pharma must look beyond its own walls to strengthen supply chain resilience. Five years after the largest pharmaceutical airlift in history, supply chains are more resilient, however the risks they face have not disappeared. The COVID-19 vaccine rollout was a relentless stress test for the pharmaceutical industry, revealing both its strengths and breaking points.  Some called the pandemic a Black Swan event – a crisis few saw coming, yet one that reshaped industries overnight. But hindsight suggests warning signs were there, and the real question is whether we are better prepared…

Niklas Adamsson, chief operating officer at Envirotainer discusses why pharma must look beyond its own walls to strengthen supply chain resilience. Five years after the largest pharmaceutical airlift in history, supply chains are more resilient, however the risks they face have not disappeared. The COVID-19 vaccine rollout was a relentless stress test for the pharmaceutical industry, revealing both its strengths and breaking points.  Some called the pandemic a Black Swan event – a crisis few saw coming, yet one that reshaped industries overnight. But hindsight suggests warning signs were there, and the real question is whether we are better prepared…

Amazon Filters is set to exhibit filters, housings and filtration solutions at FiltraTEC expo in Poland.   Amazon Filters is bringing four in-house experts to the FiltraTEC expo in Warsaw to discuss how best to optimise the value of industrial filtration technologies and filter applications.  Among FiltraTEC attendees will be senior decision makers from a host of sectors in Poland and across Eastern and Central Europe that rely on safe, robust filtration processes.  Organisers of the event, to be held at the Ptak trade fair centre in Warsaw from 13-15th May 2025, anticipate around 7,000 visitors from 15 countries.  Jan Gradoń,…

August 2025 marks two years since revisions to Annex 1 of the European Union’s Good Manufacturing Practice (GMP) guidelines were introduced. Niamh Bissett, director, business transformation at West Pharmaceutical Services discusses. Having been in development for several years, the updated guidance was widely anticipated to launch the start of a new era in the sterile manufacture of parenteral products, not just in Europe but across the world. It effectively raised the bar for companies across the pharmaceutical supply chain, challenging the sector to deliver enhanced levels of public health protection by meeting new quality benchmarks in the production and packaging of…

Orchestra BioMed Holdings, a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, has announced that FDA has approved its Investigational Device Exemption amendment to initiate an updated design of the Company’s planned Virtue SAB in the Treatment of Coronary ISR Trial. The IDE provides FDA regulatory clearance for Orchestra BioMed to initiate a U.S. pivotal clinical trial comparing its highly differentiated, next-generation Sirolimus-AngioInfusion Balloon, Virtue SAB to the Boston Scientific AGENT paclitaxel-coated balloon, currently the only drug-coated balloon (“DCB”) FDA-approved for a coronary indication. Data from the Virtue Trial will be used to support regulatory approval in the U.S.…

Sail Biomedicines’ Kerry Benenato and Rajesh Ramaswamy discuss the roles artificial intelligence (AI) can play in informing programmability, using the example of Sail’s tailored Endless RNATM (eRNATM) medicines and addressable nanoparticle delivery vehicles.  Human health and disease are complex, and the limited success of one-size-fits-all medicines has led to increased interest in personalised medicine. Tailoring medicines for small populations of patients is expensive, however, and yet, recent experience with COVID-19 vaccines has shown that adapting to changing circumstances is commercially viable with medicines that are readily programmable. How did witnessing the rapid development of COVID-19 vaccines shape the vision for…

The Novo Nordisk Foundation has announced the latest edition of its annual Challenge Programme, where for the first time it is inviting researchers from outside Denmark, in the European Schengen area, Ireland and the UK, to lead collaborations applying for grants to study four major themes. As part of its ongoing internationalisation, the Novo Nordisk Foundation is now expanding its Challenge Programme, the Foundation’s largest open competition grant programme. The Programme supports ambitious research projects that focus on creating new knowledge on major global challenges based on annually selected themes. This year, the budget for each grant has been increased…

Ramesh Jagadeesan, vice president, head of analytical services at Recipharm shares his insights on the role of analytical services in drug development. 1. What are analytical services?  Analytical services play a crucial role in the pharmaceutical industry by ensuring the quality, safety, and efficacy of drug products through rigorous scientific testing. These services encompass method development and validation, stability studies, impurity profiling, elemental analysis, and advanced characterisation techniques like Nuclear Magnetic Resonance (NMR), X-ray Diffraction (XRD), and various spectroscopic methods.  A systematic approach, such as Quality by Design (QbD) and risk-based methodologies, ensures that analytical procedures are robust and reliable. Additionally,…

PCI Pharma Services – a global contract development and manufacturing organisation (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea, a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto. Scheduled for completion in May 2025, the acquisition provides PCI with its first-ever North American manufacturing location for prefilled syringes and cartridges – including isolator technology for these formats – as well as high potent manufacturing suitable for antibody-drug conjugates (ADCs).  Althea’s robust clinical- and commercial-stage services for injectable drug products augments PCI’s deep industry experience, aligning with the company’s global sterile…

Considering the overlapping needs of a drug therapy delivered via wearable injectors, each project benefits from its own specific approach. Portescap’s business development manager for medical applications, Dave Beckstoffer, explains. This means that involving customisation from the outset can not only optimise the patient outcome, but can also streamline the development timescale for device engineers. Involving motor design expertise ensures a holistic approach throughout the development of the delivery system. In the arena of on-body injector and auto-injector development, more and more companies are creating devices paired one-to-one with a specific drug. While injector developers are still producing devices to handle…

Bruker Corporation has announced a majority investment in RECIPE Chemicals + Instruments, based in Munich, Germany. RECIPE is a European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays. The majority investment and strategic collaboration immediately enhances Bruker’s capabilities in small molecule clinical diagnostic assays with RECIPE’s ClinMASS kits for Bruker’s EVOQ liquid chromatography triple-quadrupole mass spectrometers, as well as for LC-TQ-MS systems by other vendors. In addition, the companies are preparing the introduction of high-throughput, chromatography-free (‘chrom-free’) RECIPE ClinDART kits running on flexible EVOQ DART-TQ⁺ systems that can easily switch between established LC-TQ-MS methods, and the…

CluePoints, provider of statistical and AI-driven software solutions, has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.   CluePoints was shortlisted for its new statistical innovation included as part of CMP 3.0, the Time Similarity Test (TST). TST enhances the detection of unusual patterns in electronic patient-reported outcomes (ePRO) data. By analysing audit trail timestamps, TST identifies when patients at a site enter data at unusually similar times, signalling potential fabrication or non-compliance. This enables sponsors to identify anomalies earlier and more easily, reducing timelines and costs while improving data quality and…

Suanfarma, a company specialising in the development, production, and commercialisation of active pharmaceutical ingredients (APIs) and high-value CDMO services for the health industry, has announced the appointment of Pere Mañé Godina as its new chief executive officer (CEO). This marks the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion. With a career spanning more than 30 years, Mañé has held technical and strategic executive positions at leading pharmaceutical companies such as Uquifa, Boehringer Ingelheim, and Esteve Química (Esteve Group). His experience ranges from technical and operational roles to executive positions such as…

Mabtech, a Swedish life science tools company developing immunoassay biochemical tests for research, announces a new highly  innovative image-based multiplex platform in close collaboration with research and technology specialist Qamcom. The Mabtech EYRA is a no-contact, automation-ready instrument based on a purpose-built confocal microscope, where the complete laser-based product has been designed and developed by Qamcom according to the performance wishes of Mabtech researchers. Combined with Mabtech’s advanced EYRAplex analyte kits, the complete platform is a powerful tool developed specifically for researchers in the global arena driving innovation in immunology and antibody-based vaccine and drug development. “The revolutionary new EYRA platform…

Gerresheimer, innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, is now offering complete, silicone-oil- and PFAS-free syringe systems made of glass and cyclic olefin polymer (COP). Avoiding silicone-oil significantly reduces particle load and thus minimises potential medical risks and side effects. Silicone-oil-free syringe systems are therefore particularly suitable for sensitive biologics and areas of application with particularly high requirements, such as ophthalmology. Gerresheimer has now extended its existing cooperation with the Injecto Group A/S and concluded a supply and license agreement with the Danish supplier. Gerresheimer has thus secured the long-term availability of…

Dipharma Francis, a global Contract Development and Manufacturing Organisation (CDMO) and a manufacturer of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCE), and advanced Intermediates for Generic and Contract Manufacturing markets, has announced that it has been awarded a bronze medal for its sustainability achievements by EcoVadis. EcoVadis has rated Dipharma Francis’s performance among the top 35% of all organisations surveyed, placing the Company in the 66th percentile. The assessment is based on 21 indicators across four key areas: Environment, Labour & Human Rights, Ethics, and Sustainable Procurement. This recognition reaffirms Dipharma’s ongoing commitment to sustainability and its dedication to integrating responsible…

Atelerix, a biotech company, has announced it has signed an exclusive distribution agreement with MineBio, a Chinese supply chain and logistics organisation. Under the terms of the agreement, MineBio will act as the sole distribution partner for Atelerix’s products in China, providing solutions to traditional cryopreservation challenges by enabling the storage and transport of temperature-sensitive biomaterials without freezing. Atelerix’s patented hydrogels directly address cryologistic bottlenecks by physically encapsulating cells, stabilising membrane integrity, and preserving biological function during transport. Samples can remain in a ready-to-use state at ambient temperatures for up to two weeks, eliminating the built-in costs and inefficiencies of…

Innovative filters and solutions designed to aid critical processes in pharmaceuticals manufacturing are set to feature at the forthcoming Making Pharma 2025 expo.   Amazon Filters will be at the show in Coventry, UK, to highlight the firm’s 40-year track record of providing cartridges, sanitary housings and customised solutions and support to some of the world’s biggest producers.   More than 1,700 industry professionals from around 400 companies and organisations are expected to attend Making Pharma which is this year themed on ‘compliance, innovation and sustainability’.   The two-day event features a conference and exhibition, and co-locates two separate streams, Making Pharmaceuticals and…

Shilpa Medicare announces the approval of its IND – Nor Ursodeoxycholic Acid Tablets 500 mg, by the Subject Expert Committee of CDSCO. The Committee has further recommended grant of marketing authorisation for this IND for the treatment of non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common liver disease, and it is estimated to affect about 25% of the population in World (approx. 1.2 billion) and about 188 million people suffer from NAFLD in India. If NAFLD is not treated in a timely manner, it is likely to lead to more severe non-alcoholic steatohepatitis (NASH) which could have fatal…

Steriline, a company highly specialised in the production of complete aseptic packaging lines for injectables and ophthalmic products for global pharmaceutical companies, will participate for the first time in Pharmintech (Milan, 27-30th May 2025), displaying its solutions and innovations to the public. In addition, visitors to Steriline’s stand No. B17, Hall 2 will be able to appreciate a filling and capping machine in operation, a unit that combines robotics, magnetic levitation and a containment system with a double-wall isolator. This small-scale solution is designed to attract the interest of industry professionals and pharmaceutical companies that are looking to improve manufacturing efficiency and maintain compliance with…

Verista, a provider of automation, compliance, and quality solutions for the pharmaceutical industry, highlights the COUNTQ Tray Inspection System, an AI-enabled inspection and reconciliation system designed to revolutionise the counting and verification of vials, syringes, ampoules, and other tray-loaded parts in pharmaceutical manufacturing.  The COUNTQ system offers Deep Learning AI technology for applications where rule-based vision tools are inadequate. The technology delivers 100% electronic verification of product counts in just 15 seconds, significantly increasing accuracy and throughput compared to manual methods. This innovative system virtually eliminates rework due to reconciliation and count discrepancies, while also reducing labor costs and improving worker safety.  Equipped…

American Plant Maintenance (APM Steam), a provider of steam systems maintenance services, announces its steam trap survey services, which can be used to create a full inventory of steam traps in a facility’s steam system, identify failing traps, and uncover steam trap station issues that negatively impact the delivery of thermal energy through the steam system and the proper removal of condensate.  APM Steam experts conduct steam trap surveys to test and document operational status using ultrasound and temperature differentials. Survey data provides a complete trap inventory and extensive system information in a detailed report outlining findings and recommendations, a…

Grifols has announced it will expand its offer in clinical diagnostics through a strategic partnership with IBL International. Together the two companies aim to change the clinical diagnostics landscape. Their collaboration will provide clinical laboratories with Grifols’ highly sensitive multiplexing instrumentation running IBL’s assays customised exclusively for the Grifols platform. Maximum precision, sensitivity and operational efficiency come from Grifols’ proprietary application of single molecule counting (SMC) technology, as well as full automation and random-access, which allows high sample throughput by enabling the application of individual analyte and assay types without any specific order. The combination of ultra-high sensitivity and multiplexing…

IFF Pharma Solutions, a specialist in polymer innovations, has announced the launch of Low Nitrite METHOCEL hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages. This product line addresses the industry’s concern with nitrosamine risk and mitigation strategies for their formation. Through enhanced process controls and industry-leading analytical science, IFF Pharma Solutions limits and measures the level of nitrite in every batch of Low Nitrite METHOCEL.  “METHOCEL HPMC is the polymer of choice for formulating both controlled release and immediate release pharmaceutical dosages,” said Michael Baumann, global product…

ArisGlobal, a technology company at the forefront of life sciences and creator of LifeSphere, has announced that another pharmaceutical company has chosen LifeSphere Advanced Signals, a pharmacovigilance solution that leverages automation and AI-driven insights to streamline signal detection and management. This implementation marks a significant milestone -the customer represents ArisGlobal’s largest and highest-volume deployment of LifeSphere Advanced Signals to date. The project underscores ArisGlobal’s position as the partner of choice for safety modernisation and highlights growing industry momentum toward intelligent signal automation and analytics. LifeSphere Advanced Signals, powered by NavaX, delivers measurable impact, including: 80% Faster Signal Assessment – Enable physicians to assess signals significantly faster…

DataLase and TamperTech have joined forces to introduce an innovation in tamper-evident tape technology. The development marks the first time DataLase’s photonic printing technology has been incorporated into tamper tape, combining security, authentication and tracking into a single, seamless solution.   By integrating DataLase’s pigment chemistry as a coating on paper or film within the tape, the new product eliminates the need for additional paper and plastic labels, conventional sealing tapes and traditional wet printing processes that rely on inks, solvents and other materials. The result is a more sustainable, energy-efficient and high-performance alternative that enhances both product security and supply…

Another edition of Interphex NY has ended up in a convincing demonstration of how IMA Life stays on the “crest of innovation” with its latest technology for aseptic filling, introducing a modular, fully gloveless system based on magnetic levitation: TILE-X.  TILE-X follows in the footsteps of 3 previous awards  Since winning with Lynfinity LAB in 2022, INJECTA in 2023, and KryoAir in 2024, this year’s edition saw TILE-X triumph in the Biotech Innovation Award category. This category “acknowledges an exhibitor’s innovative application to a given product or service that not only addresses an industry need, but does so in such…

Transportation of medical devices between facilities is increasingly the norm. Health care facilities often send instruments to offsite reprocessing centres miles away from the point of care. Keeping medical devices and medical device packaging intact and sterile during transportation can be a struggle. To assist health care and sterile processing professionals with this challenge, the Association for the Advancement of Medical Instrumentation (AAMI) has released a new guidance document that addresses the transportation of reusable medical devices for processing, including sterilisation. AAMI TIR109:2025; External transport of reusable medical devices for processing applies to any transportation of to-be-processed or sterile reusable medical devices between or…

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched with an integrated network across Europe, led by a team of industry experts on a mission to deliver the highest quality solutions and services to enable customers to scale to new heights and improve patient health. The firm has ten manufacturing sites and three drug development services sites, situated across France, Spain and Sweden, following the acquisition of CDMO, Synerlab Group and seven European manufacturing facilities from Recipharm last year.  Meribel Pharma Solutions is headed up by an experienced team including CEO, Bruce Vielle, formerly president, CEO of Synerlab,…

Solids handling equipment maker, Ajax Equipment, has supplied pharmaceutical developer and manufacturer, Sterling Pharma Solutions, with an ATEX-rated agitated screw feeder mounted on a mobile frame to feed an active pharmaceutical ingredient (API).   After conducting powder flow testing to determine the material’s handling characteristics, Ajax developed the stainless steel agitated feeder’s design to provide a reliable and controlled feed to downstream equipment. Powder is held in the agitated feeder’s hopper section, featuring a mirror finish, where the agitator promotes flow to the feed screw below without compacting the powder. “AJAX designed a robust feeder to suit the requirements and…

In the fast-growing injectable pharmaceuticals market, which Markets & Markets projects will reach $1139.4 billion by 2029, one innovative approach stands out as particularly valuable: topload packaging design. Andreas Koppitz, CEO of Pharma packaging at MM Group discusses. This advancement is reshaping how the industry approaches secondary packaging, particularly as the market sees unprecedented growth in biologics, GLP-1 therapies and autoinjectors.  Efficiency and safety through innovation  Topload packaging has become the go-to choice for pharmaceutical companies seeking to balance multiple critical requirements in the injectables space. This design approach offers superior protection for delicate primary containers while significantly optimising production efficiency – a…

Cold Chain Technologies (CCT) has launched a reusable universal temperature-controlled pallet shipper – the company’s first innovation for the life sciences sector since its acquisition of reusable pallet specialist, Tower Cold Chain, in 2024.  Offering a capacity of 1600L and a design that accommodates both Euro and US pallets, the CCT Tower Elite provides a singular solution for pharmaceutical companies, airlines and 3PLs looking to ship large consignments globally. Notably, the new product stands out as the lightest solution in the market for this type of temperature-controlled packaging, ensuring cost efficiency and ease of handling without compromising performance.  The CCT…

Constructing new cleanroom facilities in older buildings can be a smart and cost-effective solution for applications looking to optimise their existing spaces.  Rather than invest in completely new host buildings, it is often possible to intelligently and creatively adapt current facilities, saving both time and money. However, this approach comes with its own set of challenges.  Many older buildings have structural limitations that can impact load-bearing capacity, electrical systems, ceiling height and ventilation. Addressing these issues requires careful planning and a flexible design approach.  “We do as much as we can to work collaboratively with our clients,” says Guardtech Group…

Concept Life Sciences, an integrated drug discovery, development, and manufacturing organisation backed by Limerston Capital, has announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors. The company are pleased to welcome Professor Luke O’Neill, and Dr. Shane Liddelow to its Scientific Advisory Board (SAB), while Dr. Ian Waddell, who joined the Board of Directors last year, continues to provide invaluable leadership. The appointments to the SAB reinforce the company’s position as a partner for innovative drug discovery solutions. Professor O’Neill and Dr. Liddelow bring a wealth of expertise across immunology and neuroscience,…

The growing sophistication of pharma Clinical, Regulatory, Quality, and Pharmacovigilance process digitalisation, including the shift to data-based reporting and decision-making, is presenting a challenge to overstretched teams trying to navigate multiple different user experiences. Digital adoption platforms (a simple overlay to web/cloud-based systems) offer a practical solution, guiding users of each application, step by step, in correct, compliant data input. MAIN5’s Sabine Gölden assesses their potential.  Global estimates suggest that a typical international organisation today uses over 500 different software applications, with some individual departments possessing more than 80. In life sciences, an industry subject to strict regulations and standards,…

The Automated Plate Seal Remover from Azenta Life Sciences is a compact system for removing seals from a wide range of microplates at the single touch of a button, without damaging the plate or seal.  Hands-on removal of a seal from a microplate is a routine, seemingly undemanding laboratory task. However, removing and/or replacing tens or hundreds of seals at a time on a repetitive basis can be challenging, particularly in high-throughput and high-content screening laboratories. Even in labs that invest in automated liquid handlers or storage robotics, the unsealing and resealing of plates for sample access often remains a tedious, time-consuming, and error-prone manual process.…

Broughton, a analytical testing and consultancy firm, highlights its commitment to sustainability in laboratory operations by promoting environmentally responsible practices, ethical governance, and proactive maintenance strategies. These efforts aim to reduce the environmental impact of laboratory operations while fostering a culture of innovation and accountability.  Laboratories have a unique opportunity to make a positive impact on the environment. Broughton has implemented robust recycling programs, optimised resource use, and adopted innovative technologies to minimise energy and water consumption. By prioritising sustainable materials and methods in research and consultancy projects, Broughton sets an example for responsible and forward-thinking practices in the scientific community. …

Following the first virtual presentation at Interphex, Syntegon is now introducing its new filling machine for ready-to-use (RTU) nested syringes to the market. The MLD Advanced meets the increasing requirements of pharmaceutical manufacturers for high output with 100 percent in-process control (IPC). “Especially with high-value medicines, it is essential that each drop is filled and weighed optimally,” explains Markus Burkert, product manager at Syntegon. “That’s why we have combined the MLD platform, which was previously used primarily for cartridges and vials, with our technologies for syringe filling.”  An innovative combination of proven technologies  The automatic bag and tub openers, well-known…

Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Administration (FDA) inspection for its Unit-2 facility in Raichur, India, with no 483 observations. This marks the second consecutive clean inspection at the facility, with the FDA conducting the audit from March 10-14. This latest inspection success demonstrates Shilpa Medicare’s ongoing commitment to meeting and exceeding the highest regulatory standards and empowering its customers with both high-quality manufacturing for generics, as well as innovators through its growing CDMO division. The Company’s Unit-2 API site showcases to the FDA its state-of-the-art infrastructure,…

Infinitopes has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company’s ‘off-the-shelf’ cancer vaccine. ITOP1 is a precision cancer vaccine, designed to safely and accurately target tumour antigens, leveraging the company’s vector delivery system, aiming to drive strong and durable T-cell protection for patients with surgically resectable oesophageal adenocarcinoma (OAC). The vaccine is designed to stimulate a robust immune response, including activation of CD8+ cytotoxic T cells, to eliminate residual cancer cells expressing the target antigens, reducing the risk of disease…

Teckro has introduced its new Patient Data Return feature, providing patients with seamless access to their medical reports while giving sponsors greater oversight into engagement levels. With this latest enhancement, Teckro’s secure, user-friendly digital application now allows clinical trial participants to log in, access their assigned study documents, and share them with healthcare providers. The feature integrates directly into existing site workflows, ensuring that patient data can be managed and accessed efficiently at scale, all while aligning with global initiatives such as the TransCelerate Participant Data Return project. The solution is one of the few globally that enables patient data return…

Phastar, a specialist biometrics & data science Contract Research Organisation (CRO), has been shortlisted in the ‘CRO Partnership of the Year’ category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health (MDGH), a not for profit pharmaceutical company dedicated to the development of affordable medicines for the people who need them most.  Phastar was recognised for its collaboration with MDGH through its Phastar Cares pro bono scheme for its support on two double-blind Phase IIIb studies of more than 12,000 participants to progress moxidectin for onchocerciasis. The Citeline Award winners will be announced during an…

Gerresheimer recorded a jump in revenues and earnings due to the first-time consolidation of Bormioli Pharma, which was acquired in 2024. Revenues in the first quarter of 2025 rose by 11.6% to €520.1 million (Q1 2024: €466.1 million), while adjusted EBITDA increased by 13.1% to €91.5 million (Q1 2024: €80.9 million). The organic development compared to the pro forma figures for the prior-year quarter reflects a shift in revenues in the syringe business and subdued demand for moulded glass especially from the cosmetics sector. In organic terms, revenues fell by 6.5% in the first quarter of 2025 compared to the…

Berry Global Healthcare to showcase latest technologies for patient-centric solutions participation at this year’s RDD (Respiratory Drug Delivery) Europe Conference, taking place at the Estoril Congress Centre, Estoril (Lisbon), Portugal from 6-9th May.  The company’s Medical Devices team will present a wide range of ready-to-use platforms for inhalation therapies, which enhance the patient experience through ease of use and accurate drug delivery, as well as providing faster-to-market solutions. As part of Berry’s ‘Dose Better’ initiative, all have been developed to deliver better healthcare outcomes by improving quality of care, while helping to reduce costs.   Latest innovations on show will include the…

Ellie Gabel, Associate Editor for Revolutionized explains how cleaning and sterilisation are essential but often unoptimised processes within pharmaceutical facilities. Minimising contaminant risks is a matter of public safety, but it’s also typically time-consuming, wasteful and prone to error. Automated sterilisation technologies enhance these workflows along several fronts, even when they don’t automate the entire process. Time savings The most obvious benefit of automated sterilisation is its efficiency. Pharmaceutical demand is skyrocketing — medicine consumption has grown by 14% since 2019 and will see similar growth in the next four years. Consequently, sanitation-related downtime is a massive barrier in today’s…

Logistics4Pharma, a Frankfurt-based GDP-certified pharma logistics provider, has expanded its service portfolio. In addition to Temporary Storage under Customs Supervision, the company now offers a comprehensive transit document service with customs-secured transportation. With a complete customs service portfolio near Frankfurt International Airport, Logistics4Pharma provides fast and reliable customs solutions, enhancing flexibility and efficiency for global supply chains. “Pharmaceutical products and medical devices require time-critical solutions and specialised care during transportation and storage. Customs processes risk creating delays due to various circumstances,” states Annika Wittner, business manager & customs officer at Logsitics4Pharma. “Our customers benefit from Logistics4Pharma being a single point…

Berry Global’s presence at this year’s Maghreb Pharma Expo highlights the company’s commitment to supporting growth in emerging healthcare markets across North Africa.  Represented at two stands – Novalpac (F02) and Best Innovation (C04) – Berry will showcase a wide range of pharmaceutical packaging and drug delivery solutions. These support effective disease management and positive patient experience through improved dosing accuracy, ease of administration, and medication adherence.  All Berry solutions are supported by the company’s global manufacturing footprint, which delivers quality products, supply reliability, and high-volume output.  The products offered at Maghreb demonstrate Berry’s over 50 years of expertise and…

Reading Scientific Services (RSSL) has been awarded the title of ‘Best Performing Professional Services Company of the Year’ at the 2025 ON Awards, hosted by One Nucleus.  Judges lauded the CRO for its “exceptional” service to over 3,000 clients in 60+ countries, alongside its continued investment in services, technology and team. Their commitment to advancing scientific innovation and ambition to grow their workforce from 350 to over 500 by 2026 also stood out as key factors in securing the win.  This category was fiercely competitive, with RSSL facing strong competition from Ip21 Ltd and SRG in the final stages. However,…

After Artiva Biotherapeutics announced the news of cryopreserved allogeneic NK cell therapies (AlloNK) for treating autoimmune disease, European Pharmaceutical Manufacturer spoke to Fred Aslan, M.D., president and chief executive officer, Artiva Biotherapeutics, to learn more. 1. Can you elaborate on the differences in safety profiles between NK cell therapies and CAR-T cell therapies? Natural killer (NK) cell therapies, such as Artiva’s AlloNK, present the potential for a significantly improved safety profile compared to CAR-T cell therapies. A major advantage of NK cell therapies is their lower incidence and severity of cytokine release syndrome and neurologic toxicities, which are common and sometimes severe side…

Ray Baldwin, business development manager, Watson-Marlow Fluid Technology Solutions (WMFTS) explains how all single-use is not created equal and how you can tell the difference.  Single-use systems are becoming more popular in bioprocessing to deliver sterility and protect product integrity. But not all single-use systems are fit for purpose, especially those which were not designed for the specific application for which they are being used. Choosing the right components is vital to ensure contamination is prevented and the system is not compromised, to protect both the manufacturer and patient, and to ensure Good Manufacturing Practice (GMP) requirements are adhered to.  …

In this Q&A, David Butler, chief technology officer at Hongene Biotech answers three key questions to provide more detail about the partnership.    We recently announced that we’ll be joining forces with ReciBioPharm to deliver a gene editing development and manufacturing solution. This strategic partnership leverages our single guide RNA (sgRNA) synthesis technology and ReciBioPharm’s comprehensive contract development and manufacturing organisation (CDMO) services to streamline the development process. How did the ReciBioPharm partnership develop and what do you hope to achieve?  The partnership with ReciBioPharm began over a year ago when we visited their Watertown facility in the US to explore…

Johnson & Johnson has announced that the European Commission (EC) has approved a Marketing Authorisation for STELARA (ustekinumab) to include the treatment of moderately to severely active Crohn’s disease in paediatric patients weighing at least 40 kg, who have had an inadequate response to, or were intolerant to either conventional or biologic therapy. While Crohn’s disease is more frequently diagnosed in adults, approximately 25% of cases are diagnosed during childhood or adolescence, and is associated with a more extensive and severe disease course over time compared to adults. The onset of Crohn’s disease in paediatric patients can be triggered by various factors,…

Jeff Serle, VP of Biocontainment Solutions, Germfree, demonstrates how multimodal and modular cleanrooms can satisfy all requirements. Conflicts related to cleanroom design are elevated to a regulatory issue and require collaboration between engineers, quality professionals, regulators and researchers to resolve them. In today’s healthcare environment, the growth in Advanced Therapy Medicinal Products (ATMPs) is driving some of the largest challenges, with a critical need for high-performance manufacturing facilities. These facilities often require both biocontainment and contamination control to create an environment that can support sterile manufacturing and protect personnel and the environment from biological hazards.  Regulatory oversight for such high-performance…

4basebio, a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, has announced that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The licence enables the Company to support its customers and partners in the fields of cell and gene therapy and vaccine development with GMP-grade synthetic DNA for their clinical programs. 4basebio’s proprietary synthetic DNA platform is built to be flexible, providing high-performance DNA products tailored to specific applications. With its GMP licence, the Company is authorised to supply synthetic DNA…

Honeywell has introduced TrackWise Manufacturing, an artificial intelligence (AI)-assisted, cloud-native platform designed to transform how life sciences companies manage, automate and digitalise operations. Trackwise Manufacturing is one of the first in the life sciences industry to offer a new approach to workflow management that bridges the gap between the digital and physical manufacturing environments.  Most organisations in the life sciences manufacturing sector still rely on paper-based methods for workflow management, leading to errors and inefficiencies that cause data to go unused and can delay the introduction of new drugs, resulting in profit loss per drug. To address these challenges, TrackWise…

AMSBIO has expanded its biofluid collection and processing capabilities, to now offer a range of customisable human blood biospecimens from both healthy and disease-state donors to support biomedical research. Leveraging an extensive network of diverse donors, AMSBIO provides high-quality, ethically sourced samples tailored to specific donor demographics, sample volumes, and processing methods. Using a fully licensed sample collection and processing facility, AMSBIO can ensure the highest standards of traceability and compliance. The expanded portfolio includes leukopaks, plasma, serum, whole blood, peripheral blood mononuclear cells (PBMCs), and isolated immune cells, all processed to meet precise research specifications. Unlike national blood banks, Amsbio provides greater flexibility…

Paul Hardman, managing consultant, Broughton, explores the current situation and ways of reducing greenhouse gases in this sector.   Pressurised metered-dose inhalers (pMDIs) are essential for treating respiratory conditions like asthma and COPD, but their hydrofluorocarbon (HFC) propellants are potent greenhouse gases that contribute to global warming. As environmental concerns grow, reducing these emissions has become a priority in healthcare. The pharmaceutical industry can address these challenges by investing in research for low-global warming potential (low-GWP) propellants.   The NHS Long Term Plan aims to cut emissions by increasing the use of lower-carbon alternatives like dry powder inhalers (DPIs), greener disposal of…

MultiOmic Health, an artificial intelligence (AI)-enabled precision medicine discovery company focused on chronic multifactorial diseases, and Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratising access to drug discovery technologies, have announced they have signed a Memorandum of Understanding to jointly discover and develop first-in-class renal tissue-targeting drugs. Precision medicines for chronic renal conditions targeted to the kidney tissue of specific patient subpopulations are expected to display an order of magnitude improvement in both efficacy and safety, compared to conventional systemic drugs aimed at all patients diagnosed with those conditions. MOH has discovered certain fast-progressor patient subpopulations with poor response to existing medicines,…

Caroline Suard, global marketing manager at Tower Cold Chain, a Cold Chain Technologies company discusses the role of reliable thermal packaging solutions in pharma logistics. Maintaining precise temperature control during transportation is a necessity when it comes to pharmaceutical logistics. The efficacy and safety of life-saving medicines, vaccines, and biologics directly depend on consistent, reliable thermal protection. As supply chains become increasingly global, the demand for high-performance temperature-controlled logistics has never been greater.  A cold chain container manufacturer with a comprehensive portfolio of both single-use and reusable options ensures efficient, scalable temperature control for all transport methods, enabling safe shipment…

Biotech Fluidics announce QuickStart, a digital in-line pressure sensor that can be implemented into almost any instrument fluidic pathway.  Perfect for applications including flow cytometry, DNA sequencing, protein detection, Surface Plasmon Resonance, spatial biology and more – the QuickStart pressure sensor allows you to manage flow rates and receive accurate, instantaneous data on system performance avoiding overpressure risks as well as saving critical analysis time. Designed with an extremely low internal volume, QuickStart technology is based on a fully isolated MEMS sensing element that reacts instantly to physical pressure changes of fluid transmitted through a gel-filled cavity. Factory calibrated, this adaptive pressure sensor combines an isolated fluidic pathway, electronics,…

Beverley Wise, regional director for Webfleet, a Bridgestone company, explores how fleet tech is reshaping the pharmaceutical supply chain. In the world of pharmaceuticals, logistics isn’t just about moving products from point A to point B. It’s about delivering life-saving medications and critical supplies under precise conditions, often against the clock.  For an industry built on trust, compliance and precision, the logistical challenges are uniquely complex.   From stringent regulatory requirements, such as Europe’s Good Distribution Practice (GDP) guidelines, to the need for cold chain management, the pharmaceutical supply chain demands innovative solutions.  Fleet management platforms are increasingly at the forefront…

INEOS Enterprises has completed the sale of its composites business to KPS Capital Partners, LP (“KPS”) for c.€1.7bn.  The composites business has combined sales of more than €800m per year and employs c. 900 employees across 17 sites and 3 technology centres in Europe, North and South America, Asia and the Middle East. Andrew Miller will remain CEO of the business going forwards. The composites business is a global leader in producing resins and gelcoats that are used to make strong, lightweight composite plastics found in everything from cars and boats to buildings and electronics. Its resins and coatings help…

Olivia Friett, editor of European Pharmaceutical Manufacturer was invited to Hillerød, Denmark to see the first expansion of FUJIFILM Diosynth Biotechnologies’ facilities. Olivia spoke to Lars Peterson, president and CEO, about the expansion.  Have there been any challenges during the first phase of the site expansion?    This project was decided in early 2020 and then COVID ran through the entire globe.   I think we started the project very well, but COVID created a big supply chain issue. The flow of a great number of goods was stopped because of Suez channel issues as well as other supply chain issues. So,…

MARKEN’S PROVEN RADIOPHARMA NETWORK ACHIEVES PRECISION LOGISTICS MILESTONE. DELIVERING CRITICAL NUCLEAR MEDICINE SHIPMENTS FROM GERMANY TO THE US IN UNDER 24 HOURS GOAL Orchestrate the secure and efficient transport of critical radioisotopes via UPS Airlines from Cologne, Germany, to Louisville, Kentucky. At UPS Worldport, ensure rapid transfer to outbound flights for Houston, Texas, and Madison, Wisconsin. Upon arrival, facilitate seamless handoff to precision logistics drivers for swift final-mile delivery — maintaining constant custody and control throughout the entire journey. CHALLENGE • Airport Labor Strike: An unexpected strike in Germany impacted thirteen airports, including Cologne airport on the scheduled departure date,…

Kevin Lynch, key account manager, life sciences, Schneider Electric explains how the sector can leverage digital technologies to streamline the technology learning curve. The skills shortage is an escalating challenge across all manufacturing sectors, particularly in biomanufacturing, where the required expertise is highly specialised. To address this problem, the sector can leverage digital technologies to streamline the technology learning curve, enabling employees to focus on biomanufacturing tasks.  Biomanufacturing uses living organisms to produce commercially viable products and supports sustainability initiatives. While the skills gap affects all manufacturing fields, it is particularly pronounced in biomanufacturing and broader life sciences due to…

H&T Presspart (a division of the Heitkamp & Thumann Group), a developer and manufacturer of drug delivery components and devices for the pharmaceutical market, has announced the launch of Vytal, a ready-to-use (RTU) snap-fit closure solution for advanced therapeutics.  Vytal is designed to meet the growing demands of small- to medium-batch production of advanced therapeutics, including biologics, mAbs, and cell-based therapies.  In recent years, the pharmaceutical industry has experienced a transformative shift, with biologics and advanced therapies emerging as key drivers of global healthcare advancements. However, the production of these complex biotherapeutics presents unique challenges and the need for specific containment…

As a specialist in scalable, secure corporate payment solutions, B4B Payments continues to enhance its support for the pharmaceutical sector, offering innovative, compliance-friendly solutions to streamline operations and improve financial processes. B4B Payments, a globally recognised leader in prepaid cards and embedded payment services, has a longstanding presence in the pharmaceutical industry. Building on years of innovative payment infrastructure experience, B4B Payments is further strengthening its offering with tailored financial solutions designed to help pharmaceutical companies streamline their payment processes and ensure security, scalability, and compliance. Simplifying pharmaceutical payments The pharmaceutical industry faces unique challenges when managing complex financial transactions…

Germany, France, Belgium, Italy and the Netherlands account for up to 68% of trade in pharmaceutical products in the EU-27. This is outlined in a report prepared by Logista Freight, Logista’s long-haul, full-load transport subsidiary. It analyses the pharma sector’s trade relations within the European Union, a market that moves 3.3 million tonnes per year, amounting to more than 250 billion euros.  The report gives an overview of the main trade flows among Member States, with trade from Ireland to Belgium, from Germany to the Netherlands and from the Netherlands to Germany in the top positions. The results of this assessment…

Steriline, a European manufacturer of highly specialised robotic filling machines and complete aseptic filling/finishing lines, will attend Interphex. The company will welcome visitors on 1-3 April at stand 2537 in the Javits Center, NYC, displaying a Robotic Vial Filling Machine utilising Planar Motor technology, a magnetically levitated transport system.  The solution consists of a unique platform that levitates movers above a stainless surface providing 6 degrees of precise motion and zero friction. This allows for the transport of containers (vials, syringes, cartridges, etc.) from station to station in the filling and closing operation, without any mechanical components or particle generation. The…

PSG Biotech is showcasing bioprocessing efficiency at INTERPHEX 2025 with its single-use flow control solutions. The launch takes place 1-3 April at the Javits Center in New York City, where bioprocess professionals will witness firsthand how PSG’s precision technology is reshaping pharmaceutical manufacturing.  Visitors can explore PSG Biotech’s flow control technologies, headlined by the dramatically enhanced SumoFlo Single-Use Coriolis Flow Sensor portfolio – a technology that’s “redefining accuracy standards” in the industry.  The SumoFlo “represents a leap in single-use Coriolis flow sensor technology”. The spotlight falls on the newest breakthrough – the CSEN-8103-032 sensor – which shatters previous limitations with a flow range spanning 20…

Daniel Jones, marketing specialist, ZwickRoell highlights advances in parenteral drug delivery products and testing methods. Pioneers in the pharmaceutical industry quickly understood the medical benefits of parenteral drug delivery. Decades worth of evolving systems that promised to optimise and fine-tune efficacy, safety, and patient comfort precede today’s on-body-delivery systems. And as the industry continues to move the needle forward to meet even higher expectations while adhering to increasingly intricate and strict standard requirements, collaborative efforts from testing equipment manufacturers remain essential.  From the early invention of glass syringes in the 1940s to the introduction of autoinjector technology for military use…

Verista, a provider of automation, compliance, and quality solutions for the pharmaceutical industry, is excited to announce its participation at INTERPHEX 2025, on 1-3rd April at the Jacob Javits Center in New York City, NY, at booth 2860. Verista will be exhibiting its latest products and services, highlighting the COUNTQ Tray Inspection System, an advanced AI-enabled inspection and reconciliation system designed to revolutionise the counting and verification of vials, syringes, ampoules, and other tray-loaded parts in pharmaceutical manufacturing. Verista’s technical experts will also be at the booth.  The COUNTQ system delivers 100% electronic verification of product counts in just 15 seconds, significantly…

Stephen Cawley, chief compliance officer, Biocair shares the challenges and innovations in sustainability for the life sciences supply chain. Sustainability is no longer a peripheral concern but a central strategic goal for businesses. Achieving sustainability goals within the life science industry involves navigating a complex web of supply chain challenges while maintaining the quality and safety of sensitive products.   The importance of the supply chain in meeting sustainability targets  The supply chain forms the backbone of the global pharmaceutical ecosystem, enabling the movement of sensitive, high value and potentially lifesaving products across the globe. Its significance in helping us achieve…

Pfizer Global Supply (PGS) produces over 23 billion doses of medicine annually across its network of 42 global sites. In 2016, the division embarked on a journey to optimise operations and support Pfizer’s overarching purpose of “breakthroughs that change patients’ lives.” The goal was to revolutionise the company’s manufacturing operations, leveraging data-driven insights to drive world-class performance. This initiative began with the leadership of the president of PGS. PGS’ network of facilities, stemming from more than 30 legacy pharmaceutical companies, relied on a wide range of systems and datasets, each with unique standards and protocols. As a result, obtaining actionable insights…

CARBOGEN AMCIS has announced that it has successfully secured GMP Certification at its sterile drug product manufacturing site in Saint-Beauzire, France. The French regularity authority ANSM (Agence nationale de sécurité du médicament et des produits de santé) conducted its first inspection from the 20th to the 24th of January, earlier this year. This inspection is a routine process conducted by the ANSM as it ensures the company is complying with Good Manufacturing Practices (GMP). Following the successful completion of the inspection, the pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company received its GMP certificate for its facility, which opened in…

Avantor, a global provider of mission-critical products and services in the life sciences and advanced technology industries, presented highlights of the recently completed expansion at its flagship European manufacturing site at Drug, Chemical & Associated Technologies Association (DCAT) Week 2025. Dr. Brophy’s presentation took place on 17th March. DCAT, which runs 17-20th March in New York City, is an annual event for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain.  The new production facility’s advanced technologies quadruple the site’s capacity for manufacturing, formulating, and filling United States Pharmacopoeia (USP) purified water and Water for Injection (WFI)-based hydration solutions. These high-purity solutions are essential…

BrePco Biopharma (BPCO) and Piramal Critical Care (PCC) has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) issued a grant of a Marketing Authorisation for the use of Neoatricon – the first paediatric strength solution for infusion of Dopamine Hydrochloride.   PCC has secured the commercialisation rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions. Developed by BPCO, Neoatricon is an age-appropriate, ready-to-use, sterile solution for infusion of Dopamine Hydrochloride. It is available in a concentration of 1.5mg/mL in a 30 mL vial and a higher strength containing 4.5mg/mL in a 50 mL vial. Paul Breen, director of BPCO said: “The approval of this…

American Plant Maintenance (APM Steam), a provider of steam systems maintenance services, highlights its innovative HVAC insulation services, designed to provide significant energy savings and enhanced operational efficiency for biopharmaceutical and pharmaceutical facilities. APM Steam’s team of experts can quickly assess insulation opportunities, and work directly with top insulation manufacturers in the country to capture significant energy savings.  The Heat Loss Study offered by APM Steam includes a detailed site walk and thorough review of hot water, steam, and chilled water plants and distribution systems. An engineering team delivers a full review of findings, offering actionable recommendations to repair faulty…

Beckman Coulter Life Sciences and an Operating Company of Danaher Corporation, “revolutionises” spectral flow cytometry with the industry’s first modular solution: the CytoFLEX mosaic Spectral Detection Module. When connected to the CytoFLEX LX or S Flow Cytometers, the CytoFLEX mosaic Spectral Detection Module delivers superior fluorescence sensitivity for dim and complex multicolour experiments and can detect nanoparticles as small as 80 nm. It uniquely provides two unmixing algorithms and up to 10 autofluorescence channels, with up to 88 detection channels. The richer data resulting from spectral analysis can help untangle the complexities of biological systems and diseases faster, with a nuanced understanding of…

Carrier Global Corporation announces the launch of Carrier Lynx FacTOR, a software-as-a-service (SaaS) solution designed to transform product release processes in the pharmaceutical industry.  Lynx FacTOR automates end-to-end product release evaluations, minimising manual processes and safely accelerating product movement in the cold chain. The name FacTOR represents the critical impact of ‘time out of range’ in supporting product quality and patient safety. Pharmaceutical companies face numerous challenges in ensuring product integrity throughout the distribution journey. Manual processes, costly delays, siloed data and strict compliance requirements often hinder timely product releases at their next or final destination. Current processes can involve manual…

Sapio Sciences, the science-aware lab informatics platform, has announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery. With the BioNeMo platform, researchers can accelerate drug discovery by leveraging science-specific AI frameworks, pre-trained models, and generative AI tools to streamline the identification of potential drug candidates and improve target selection accuracy. NVIDIA BioNeMo provides scientists with a framework for training and deploying large biomolecular language models at supercomputing scale. The integration of BioNeMo into the Sapio Platform…

Cold Chain Technologies (CCT) and Tower Cold Chain are set to make their biggest appearance yet at LogiPharma 2025, taking place in Lyon from 8-10th April. For the first time since joining forces, the two companies will present a united front, showcasing their latest innovations in temperature-controlled logistics for the pharmaceutical sector.  With a shared commitment to performance, sustainability, and global accessibility, Tower and CCT will be exhibiting at Booths 91A and 68, where they will unveil their newest product designed to set new benchmarks for efficiency, reliability, and sustainability in cold chain shipping.  As part of the “Let’s Go Further”…

Domain Therapeutics has announced it has nominated and is progressing DT-9046, a candidate with “game-changing” potential in multiple inflammatory disease markets, including atopic dermatitis (AD), inflammatory bowel disease (IBD), arthritis but also neuroinflammation including migraine. PAR2 has emerged as a pivotal therapeutic in inflammatory diseases due to its unique ability to fine-tune immune and inflammatory responses, barrier integrity, and pain, however it is proven to be a difficult receptor for the pharmaceutical industry to target effectively. By leveraging Domain’s expertise to address challenging GPCRs, DT-9046 represents a groundbreaking advancement in PAR2 modulation employing a differentiated mechanism of action, targeting an allosteric…

With increasing regulatory requirements and the need for full traceability, manufacturers are turning to advanced technologies like EyeVision Software to streamline quality control processes. Offering solutions for code reading, quality inspection, and seamless integration into production lines.  The pharmaceutical industry operates under some of the most stringent quality standards in the world. Every product must meet strict specifications to ensure safety and efficacy. Strict regulations require every product to be meticulously documented and tracked, from production to delivery. Compliance with FDA standards, including 21 CFR Part 11, is crucial for ensuring the integrity of electronic records and signatures. EyeVision Software…

Marcelo Cruz, VP of business Development and Marketing at Tjoapack, explores the secondary innovations poised to revolutionise the patient centricity of PFSs over the next decade. The global prefilled syringe (PFS) market was worth $7.91 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% to reach $20.62 billion by 2032. Europe dominated the global market in 2023 with a share of 40.33%.  One of the key reasons behind the success of the PFS format is the improved patient experience it offers. Coming already charged with a single dose, the PFS allows patients…

LCP has developed a new platform, Medicines Oracle, that will aid in understanding how medicines are used across the NHS.  Using AI technology, the tool allows users to track NHS medicines usage across all GP practices and NHS hospitals, map these against health metrics, and dig deep into understanding variation in medicines use. This will be particularly helpful for stakeholders in medicines optimisation and usage, such as pharma companies and ICB and national commissioners.  The tool can also analyse prescription trends alongside disease prevalence and NHS performance metrics, meaning that NHS and industry stakeholders will better be able to understand variation…

Charles Virden, founder and CEO of VitalTE, and Lisa Stehno-Bittel, president and founder of Likarda, discuss a new approach to HRT delivery that would allow self-administration through infrequent injection. Sex hormone deficiency affects nearly one-third of all men over 70 years of age as well as nearly all post-menopausal women, who experience dramatic drops in oestrogen levels. Hormone replacement therapies (HRTs) for women during or after menopause and for men with hypogonadism have been a mainstay of treatment for conditions related to ageing for nearly 100 years, with various forms of administration.  Despite the prevalence of need, such therapies are…

SGD Pharma highlights its investments into the next-generation of glass manufacturing and commitment to strengthening pharma supply chains in the US and beyond. DCAT Week takes place between 17th-20th March 2025 and is one of the most influential gatherings for pharmaceutical and biotech companies from across the world, providing a powerful platform for high-level discussions, networking and collaboration with key industry leaders. SGD Pharma has committed multi-million-euro investment in recent years to modernise its global manufacturing sites, strengthen its high-precision vial production to meet growing pharma demand and upgrade its furnaces to reduce carbon emissions and energy use. SGD Pharma has been…

Harvey Branton, senior translational consultant at cell and gene therapy CDMO eXmoor Pharma, shares invaluable insights into early process development, exploring common misconceptions that could impact long-term manufacturing success for ATMP developers. Recent scientific advances are driving an increase in the number of advanced therapeutic medical products (ATMPs) coming to market, and keeping costs under control is essential to support the democratisation of these life-changing therapies. Traditionally, biomanufacturing relies on process optimisation and scale-up to drive down costs. Unfortunately, these approaches do not translate to an autologous therapy where each batch is personalised and made from a patient’s own cells.…

mAbTree Biologics has signed an exclusive co-development and commercialisation partnership with Shilpa Biologicals Pvt, a fully owned subsidiary of Shilpa Medicare, for its biologic asset for immuno-oncological applications. Under the terms of the strategic agreement, Shilpa Biologicals will support both development – including clinical studies – as well as long-term commercial supply with GMP manufacturing. Additionally, Shilpa Group will provide mAbTree access to India and several global markets through its extensive partner network. This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation and generation of strong immune responses against tumours akin to the…

Aimee Hodge, VP business operations development & manufacturing at PCI Pharma Services discusses PPQ pitfalls and how to avoid them. For just a moment, let’s imagine we remove our pharma engineering hats and slip into… running shoes. Let’s swap out our dedication to drug development and manufacturing and replace it with weeks, months and even years of physical training all for one goal: completing a marathon.   To say you’ve put in the work is an understatement. Long hours in the gym, longer hours on the track. Trading pizza for protein shakes and carrot cake for, well, carrots. Running through pain,…

To celebrate 25 years, LogiPharma looks back on previous shows and how it’s evolved. The past quarter-century has been one of remarkable change for the pharmaceutical and life sciences industry. Scientific breakthroughs, shifting regulatory landscapes, and major global events – most notably the COVID-19 pandemic – have redefined how medicines and medical devices are developed, manufactured and distributed.   In this rapidly evolving environment, supply chains are no longer just about logistics. They must be resilient, data-driven, and patient-centric. This shift is why LogiPharma has evolved from a niche logistics event into a forum addressing the full spectrum of challenges and…

It’s been a few months since I stepped into the role of editor at EPM, and in that time, one topic has consistently stood out in conversations, industry events, and press releases—sustainability.

BGS US recently acquired quality certifications for ISO 13485 and ISO 9001, and the confirmation of ISO 11137 for its 100,000- square-foot Electron Beam (E-Beam) sterilisation facility in Imperial, PA. The facility will begin operations in mid-2025. The cerificaion audit was conducted by DQS Medizinprodukte from 7-10th January, 2025, and verified that BGS US meets all requirements without any non-conformities. “This significant milestone marks a crucial step for our company and underscores our commitment to the highest levels of quality and customer satisfaction,” said Leonard Zuba, general manager, BGS US. “It also keeps us on schedule to begin operations as planned.”…

42 Technology (42T) has joined forces with industry experts in machine vision, edge AI silicon and software – Balluff, Synaptics and Arcturus Networks – to help develop and demonstrate a breakthrough approach for AI-powered automated line clearance in pharmaceutical manufacturing.  The four partners have pooled their technology expertise and application knowledge to develop a lower cost, flexible, and scalable alternative to existing AI-powered automated technologies. Most dedicated systems designed to automate line clearance processes are too expensive for widespread use because of their high hardware costs, complex integration, and the need for extensive training on production lines.  The new approach, which…

i-team Global launches the SAFE-T product family, the “world’s first” battery-powered cleanroom floor cleaning range. These innovations help businesses keep contamination out of critical environments while saving time, reducing costs, and addressing staff shortages.  Combining stringent floor cleaning ability, ergonomic design and efficient battery systems, these trailblazers transform controlled environments. Industry sectors such as high-tech, semiconductors, medical devices, healthcare, pharmaceuticals, and food production can now meet the required cleanliness standards with less effort.  Activate SAFE-T Superpowers  Traditional cleanroom floor cleaning relies heavily on manual wiping and mopping, which is time-consuming and inconsistent. With powerful mechanical scrubbing and Ultra-Low Particulate Air…

Syngene International, a contract research, development, and manufacturing organisation (CRDMO), has announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines. The biologics facility, acquired by Syngene USA, a wholly owned subsidiary of Syngene, from Emergent Manufacturing Operations Baltimore (a subsidiary of Emergent BioSolutions Inc.), will expand Syngene’s growing global biologics footprint to better serve its customers across both human and animal health market segments. The new site will increase Syngene’s total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services. Additionally, it will provide Syngene’s customers…

Antares Vision Group will offer live demonstrations of a high-speed system providing 100% inspection and leak detection for liquid-filled glass containers at INTERPHEX NYC, 1-3rd April in New York. At its Booth #2821, Antares Vision Group also will showcase a high-speed serialisation station for bottles of various shapes and sizes; a manual station suitable for a wide range of containers; and a standalone module for semi-automatic case aggregation.  Across Antares Vision Group’s core strengths of traceability and inspection, the solutions highlighted at INTERPHEX share several commonalities. Perhaps most prominently, each can be deployed as integrated modules into existing production environments, an…

Dyne Testing, an Intertronics brand, presents the Sigma 702 Force Tensiometer from Biolin Scientific, a standalone instrument for precise surface tension and interfacial tension measurement. The Sigma 702 Force Tensiometer features a precision balance, motorised sample stage and an intuitive user interface, meaning minimal training is required for operation.  A force tensiometer measures surface tension by determining the force required to detach a probe or ring from the liquid’s surface, that force being directly related to the liquid’s surface tension. Sigma 702 Force Tensiometer has a motorised sample stage, and an ultra-sensitive balance. The integral control screen allows you to simply…

Adragos Pharma, a contract development and manufacturing organisation (CDMO), has announced the completion of a €4 million project to install and commission an advanced, cGMP-compliant liquid filling line and accompanying cartoning machine at its facility in Leipzig, Germany. The new capabilities will offer nearly ten times the production capacity at the site, enabling the company to meet rising demand while maintaining the highest standards of quality, efficiency, and compliance. The new line has the capacity to fill up to 13 million bottles per annum in various formats to supply pharmaceutical, cosmetic, and healthcare supplement products. The installation project initially involved…

In the chemical and pharmaceutical industries, mixtures of substances must often be separated. However, if the substances to be separated have similar boiling points or the energy required must be minimised, conventional extraction processes quickly reach their limits. Instead, extraction processes in which the substance mixtures are pulsed in extraction columns make technical and economic sense. The bellows pulsator from LEWA ensures particularly harmonious pulsation that is gentle on both the medium and the system itself. Thanks to precisely adjustable amplitude and frequency, the system can be optimally adapted to different mixtures of substances and separation tasks. Because the robust,…

Rimkus Consulting Group has announced the acquisition of Human Factors Consulting Services, Incorporated (“HFCSI”), a highly regarded firm specialising in proactive human factors services and medical device consulting. This acquisition strengthens Rimkus’s position as a leader in the human factors consulting industry, expanding its technical expertise and enhancing its client offerings. “HFCSI’s deep specialisation in human factors engineering and medical device consulting complements our own expertise and enhances our ability to deliver holistic solutions to clients worldwide. The synergies between Rimkus and HFCSI will drive continued success as we work together to solve complex challenges,” said Charles Burhans, senior vice president, specialty…

In biopharma manufacturing, every second counts. Like in any industry, operational downtime breeds inefficiency. In the context of manufacturing, it can delay critical research, disrupt production and as a result, impact the people in need of the products developed.   Regulatory compliance and precision are vital parts of the biopharma industry – making smart, adaptable asset maintenance strategies more than just a nice-to-have, but a strategic advantage. However, that strategy can be difficult to implement among siloed works, requiring customer-focused workplace solutions and a foundation of trust. A fully integrated engineering approach can self-deliver critical services that keep manufacturing spaces compliant,…

The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.  That’s why Stevanato Group has developed novel solutions designed to help clients work with complex, sensitive and hard-to-stabilise monoclonal antibodies (mAbs). Its glass drug containment solutions and drug delivery devices are combined with state-of-the-art analytical services, reliable technologies and manufacturing equipment.  One of the key challenges with mAbs is the stability, potency and safety of the drugs over time and the fact that…

NewAge Industries Inc., parent company of the AdvantaPure brand of high-performance pharmaceutical and biopharmaceutical tubing and hose, proudly cut the ribbon on their new European based manufacturing site in May of 2024. This strategic expansion underscores AdvantaPure’s commitment to serving its global clientele with enhanced efficiency and sustainability.  Located in the scenic countryside of Coevorden, Netherlands, the facility was cleared for full operations earlier this year and will now serve as the primary production hub for orders destined for Europe, the Asia Pacific region, and other Eastern Hemisphere industry partners.  In alignment with the organization’s global sustainability initiatives, the new…

The Feb/Mar 2025 issue of European Pharmaceutical Manufacturer explores the latest packaging trends, a Q&A with FUJIFILM Diosynth Biotechnologies, Drug Delivery & Devices plus Biopharma and Manufacturing insights alongside NewAge Industries as our Cover Story. 

Johnson & Johnson has announced new icotrokinra (JNJ2113) data from its comprehensive Phase 3 clinical programme and the start of the first head-to-head study in plaque psoriasis (Pso) seeking to demonstrate the superiority of an oral pill, icotrokinra, compared to an injectable biologic, ustekinumab.  Icotrokinra is a first of its kind investigational targeted oral peptide that selectively blocks the IL-23 receptor and is being studied in adults and adolescents 12 years of age and older with moderate-to-severe plaque Pso. Data from the Phase 3 ICONIC-LEAD study, presented as a late-breaking abstract at the 2025 American Academy of Dermatology (AAD) Annual Meeting,…

Limula has unveiled LimONE, a disruptive cell therapy manufacturing solution that automates complex and fragmented processes into a seamless workflow. Through consolidation of multiple unit operations into a single closed consumable, LimONE enables end-to-end production of these highly personalised treatments—reducing labour, equipment, and infrastructure costs while ensuring process standardisation and scalability. LimONE was officially presented by Luc Henry, CEO of Limula at Advanced Therapies Week in Dallas, Texas, on 22nd January during the Innovation Zone Tech Spotlight Session. LimONE is designed for both hospitals and biopharma companies, providing a versatile tool that supports the production of multiple types of cell therapy, including CAR-T and gene-edited…

New research has revealed up to 70,000 additional jobs will be needed in the UK life sciences sector over the coming decade, if recent growth trends continue. Published today, the new report from the Futures Group – Life Sciences 2035: Developing the Skills for Future Growth – also shows as many as 75,000 additional employees could be needed to replace those leaving the workforce over the same period. The report calls for action to enhance education and training pathways, promote lifelong learning, build interdisciplinary skills and foster inclusive workplaces which attract and retain diverse talent. The government has identified life sciences as…

Centauri Therapeutics (Centauri), an immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic indications, has announced the selection of its first clinical candidate in the ABX-01 programme. Based on the Company’s Alphamer platform, the compound is designed to target serious Gram-negative bacterial infections in the lung, expanding therapeutic options for the most vulnerable patients. This drug candidate will now be further developed ahead of progression to first in-human clinical studies. The lead candidate in the ABX-01 programme is a broad-spectrum antimicrobial peptide specifically selected to combat clinically prevalent and multidrug-resistant bacterial strains. It employs a dual mechanism…

Beckman Coulter Life Sciences in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research. Under a co-exclusive distribution agreement between the two companies, Beckman Coulter Life Sciences will market and distribute the Rarity Bioscience AB superRCA technology assays. This expands the global reach of this pioneering new solution which accelerates the detection of mutations by using flow cytometry with logarithmically higher sensitivity compared to current gold standard digital PCR (dPCR) method. While traditional flow cytometry research analyses phenotypes, this platform combines a molecular assay based on rolling…

Cold Chain Technologies (“CCT”), a global provider of advanced thermal packaging and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, has announced it has acquired Global Cold Chain Solutions (“GCCS”), a provider of passive cold chain solutions primarily in Australia and India.  GCCS designs and manufactures high-performance thermal assurance solutions for a diverse array of life sciences applications. Its robust thermal engineering capabilities and core network of manufacturing sites across Australia and India enable the safe and reliable transportation of life-saving drugs. GCCS utilises proprietary product designs and manufacturing processes to meet the needs of its blue-chip life sciences customers globally.   “GCCS…

International Women’s Day is a day to honour the incredible accomplishments women have made across all industries. Olivia Friett, editor of European Pharmaceutical Manufacturer, shares insights from women leaders in pharma. Despite facing inequality through the years, women in pharma have consistently broken barriers, achieved milestones, and paved the way for future generations of leaders and innovators. Women in history One of the most iconic women in the history of pharma is Marie Curie, a physicist and chemist. Curie’s discovery of radioactivity and her work with radium and polonium revolutionised cancer treatment. Despite facing gender-based discrimination throughout her career, Curie…

For the 25th time, big pharma and logistics players will come together at LogiPharma 2025. This milestone anniversary event, taking place this April in Lyon, will unite the top minds from these closely related industries to tackle the most urgent challenges facing the global supply chain.  With 180 sponsors and over 2,000 attendees confirmed, the 2025 edition will feature an extensive exhibitor zone with 150 stands, dedicated industry tracks, and exclusive insights from some of the most influential voices in pharma supply chain management. From global pharmaceutical giants and logistics powerhouses to emerging biotech innovators, LogiPharma continues to provide an essential…

Milan Libánský, marketing specialist at Quinta-Analytica discusses anaemia, a serious medical condition affecting millions of people worldwide, characterised by a lack of healthy red blood cells to carry adequate oxygen to the body’s tissues. This condition can lead to fatigue, weakness, and various health complications if left untreated. According to the World Health Organisation, anaemia affects approximately 1.62 billion people globally, with iron deficiency being the most common cause. Anaemia can be treated with various medications, including iron supplements, vitamin B12 injections, and specific iron complexes like Ferric carboxymaltose (FCM). FCM is a well-tolerated form of iron available in both tablet…

Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s Tezspire (tezepelumab) significantly reduced nasal polyp severity, the need for subsequent surgery, and systemic corticosteroid use in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) compared to placebo.  These data were published in the New England Journal of Medicine and presented as a late-breaking oral presentation at the American Academy of Allergy Asthma & Immunology (AAAAI)/World Allergy Organisation (WAO) Joint Congress in San Diego, CA. Treatment with Tezspire significantly reduced nasal polyp severity measured by the co-primary endpoints; Nasal Polyp Score (NPS) by -2.065 (95% CI: -2.389, -1.742; p<0.0001) and nasal…

Novo Holdings and TA Associates, has announced that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites, an international medical devices company that engineers, manufactures and markets leading products for use in infection management in bone and soft tissue. As part of the transaction TA, Biocomposites’ majority shareholder since 2017, will reinvest in the Company alongside new investor Novo Holdings and Biocomposites’ management. The transaction gives TA and Novo Holdings shared control of Biocomposites. Headquartered in Keele, United Kingdom, Biocomposites’ pioneering calcium compounds and specialty polymer products – including STIMULAN, the only calcium matrix…

Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of an indication extension of DARZALEX (daratumumab) subcutaneous (SC) formulation in the frontline setting. The recommendation is for daratumumab SC in combination with bortezomib, lenalidomide, and dexamethasone (daratumumab-VRd) for the treatment of adult patients with newly diagnosed multiple myeloma (NDMM).  “It is increasingly evident that to continue optimising outcomes in multiple myeloma, we must intervene early with the most effective therapies first,” said Edmond Chan, MBChB, M.D. (Res), EMEA Therapeutic Area…

Rob Shaw, GM EMEA at Fluent Commerce, answers the questions: “How can pharmacies address supply chain and operational efficiency challenges?” Over the past few months, pharmacies in England, Wales and Northern Ireland have voted to cut opening hours and reduce the number of home deliveries in a protest over government funding. It forms part of a wider picture that has seen pharmacies come under significant financial pressure, with challenges such as thin profit margins contributing to the closure of 700 outlets in England alone during the past two years, according to reporting by the BBC.   Many are also faced with ongoing supply…

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, has announced a collaboration with Gustave Roussy, the first European cancer centre, to identify non-invasive biomarkers for immune-related adverse events (irAEs) in patients undergoing immunotherapy. Immunotherapy, particularly immune checkpoint inhibitors targeting PD-1/PD-L1 and CTLA-4, has revolutionised cancer treatment by harnessing the immune system to fight tumours. However, these therapies can trigger severe and sometimes life-threatening autoimmune side effects, especially in combination regimens. Predicting which patients are at risk of developing these toxicities remains a significant challenge. The PREMIS study, promoted by Gustave Roussy, is an interventional research…

BioProduction by SEKISUI’s Kirsty Bellchambers and Aurore Laborie-Thompson share insights into what drug developers need to know about transferring their biologics processes to a CDMO partner.  Biopharma developers may choose to partner with a contract development and manufacturing organisation (CDMO) at various points as they progress their program, to develop, transfer, and/or scale-up manufacturing of their proteins. Depending on the relative maturity of the program, there can be any number of internal processes developed that must be replicated with a partner. Therefore, technology transfer may look different from one program to the next, depending on both unique aspects of the process…

According to Gerresheimer, revenues reached €2,035.9m (2023: €1,990.5m), while adjusted EBITDA amounted to €419.4m (2023: €404.5m). Organic sales grew by +2.9% and adjusted EBITDA by +4.1%. The adjusted EBITDA margin improved to 20.6% (2023: 20.3%). The Plastics & Devices Division benefited from the strong growth in medical devices, partially offsetting the destocking effects in the vial business in the Primary Packaging Glass Division. The first signs of a market recovery in the vial business were seen in the fourth quarter of 2024, but destocking effects at customers weighed on the results of the Primary Packaging Glass Division in the full…

Johnson & Johnson has announced data from the Phase 3 ASTRO study of TREMFYA (guselkumab) subcutaneous (SC) induction therapy in adults with moderately to severely active ulcerative colitis (UC) at the 20th Congress of the European Crohn’s and Colitis Organisation (ECCO). Study findings through Week 12 showed statistically significant and clinically meaningful improvements compared to placebo across all clinical and endoscopic measures.   “The Week 12 results from the ASTRO study build on data from the QUASAR study demonstrating that both guselkumab subcutaneous and intravenous induction achieved clinically differentiated results in patients with moderately to severely active UC,” said Laurent Peyrin-Biroulet,…

Thames Freeport, in collaboration with Rainmaking and Care City, has launched their health and care accelerator with a cohort of six innovative Korean startups, each tackling critical health and care challenges facing the UK’s ageing population. Proven in Korea, their solutions present new opportunities to improve health and care outcomes, and drive down costs for the NHS, care services, and local authorities – benefiting communities in the Thames Freeport region and beyond. Thames Freeport is a venture that aims to improve people’s lives in London and the surrounding boroughs to the east. With an ageing population and a system already under strain, transforming…

To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and engaging more deeply with physicians and experts.  “The only thing that was impossible was to do nothing.” These are the words of Terry Pirovolakis, CEO of Elpida Therapeutics, and father to Michael who was diagnosed as an infant in 2019 with an ultra-rare neurological condition, SPG50. Despite being told there was no cure, Terry moved mountains over four years to find a breakthrough gene therapy that his son and other affected children all over the world could benefit from.  Michael, Terry, and…

When it comes to a controlled environment, where the complexity of engineering, layout and performance is so vital to preventing contamination and protecting process and yield, the fundamental building blocks of a project simply cannot be ignored.  It’s one of the reasons the Guardtech Group have invested so heavily in bolstering their Design Team over the past four years, with the Suffolk contamination control experts quadrupling their numbers from three permanent cleanroom design specialists to 12.  With three highly experienced Directors also involved in the Design process, it gives the Guardtech Group, and its subsidiary cleanroom construction brands Cleanroom Solutions,…

Datapharm, a provider of medicines information in the UK, has announced its continued expansion into Europe through a new strategic partnership with VIDAL. This collaboration will make Datapharm’s Scientific Response Document (SRD) Search technology accessible to healthcare professionals (HCPs) in France via VIDAL’s trusted medicines information platform. The partnership has already secured interest from 11 pharmaceutical companies.   Many HCPs struggle to find reliable answers online to their questions about medicines. To address this need, Datapharm collaborated with Medical Information Leaders in Europe (MILE) to develop innovative SRD search technology. The technology enables HCPs to retrieve accurate responses 24/7 and has already…

The Indian Contract Research, Development, and Manufacturing Organisation (CRDMO) sector is at an inflection point, with the potential to grow to $22 – $25 billion by 2035, as revealed in a new report, Unleashing the Tiger: Indian CRDMO Sector 2025, published by Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organisation (IPSO). The report highlights India’s strong foundation in small molecule capabilities, sustainable cost advantages and emerging biologics expertise, positioning the country as a global leader in pharmaceutical innovation. Key findings from the report India’s CRDMO market is growing at a 15% CAGR, outpacing global industry growth, fueled by its cost…

ProductLife Group (PLG) has announced the acquisition of HERAX Life Science, a Danish business and technology consultancy providing tailored services and solutions for the life sciences industry. Founded in Copenhagen in 2009, HERAX Life Science has established itself as a highly specialised business and IT consultancy, supporting life sciences companies in digitising R&D activities, selecting and delivering technology solutions, and optimising business processes within clinical development. Supported by a team of industry experts, HERAX Life Science leverages methodology, deep process understanding and technology to help clients enhance their R&D efforts and achieve better outcomes. This acquisition unites HERAX Life Science…

VarmX, a biotech company developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has been awarded a follow-on equity investment of €15 million from the European Innovation Council (EIC) Accelerator. The funds received from the investment will be used for the further development of its lead compound, VMX-C001. VarmX has been selected by the European Innovation Council (EIC) for funding and is one of only five companies to receive follow-on equity investment through the EIC Fund, Europe’s largest deep-tech investor. This funding round was the most competitive since the…

Oxford Drug Design has been awarded £1m in funding to progress its uUTI (uncomplicated urinary tract infection) antibacterial programme, as announced by PACE (Pathways to Antimicrobial Clinical Efficacy). PACE will support novel antimicrobial projects over the next three years, with Oxford Drug Design set to receive £1m to accelerate the optimisation of its novel therapeutic against uUTIs. In the UK, there were over 1.8 million hospital admissions involving UTIs between 2018-19 and 2022-23, with the condition being responsible for around 236,000 deaths in 2019. UTIs are also the most common outpatient infections in the United States, with between 50% and…

Marcelo Cruz, vice president of marketing and business development at Tjoapack, discusses the trends changing the contract packaging industry, explains how Tjoapack ensures continued growth and shares his hopes for the industry’s future. What broader trends are you seeing in the contract packaging industry?  There is a growing need for smaller batch sizes, especially in biologics, such as personalised medicines. This approach greatly increases the complexity of the supply chain. Larger companies may not be fast or flexible enough to take on these small-batch projects, but experienced and flexible contract packaging organisations (CPOs) can help address this need. This is…

Berry Global will demonstrate its market leadership in innovative packaging solutions for natural, organic, and healthy lifestyle products at this year’s Expo West exhibition, being held at the Anaheim Convention Centre, California, USA, from 4th to 7th March.  On Stand 2497 in Hall C, Berry will present its wide range of patient-centred packs for markets including OTC medicines, vitamins, supplements, and nutraceuticals, which combine ease of use and functionality with circular design.  A major highlight will be the company’s recently launched ClariPPil pill bottle range, a clarified polypropylene (PP) alternative to coloured PET versions that offers significant benefits in areas such…

In this article, Max van Heeswijk, IT manager at Tjoapack, explores how the digitalisation of pharmaceutical packaging and the broader supply chain, as well as the introduction of smart packaging, can help pharmaceutical companies make their products fit for the future. He also explains how companies can unlock the potential of these new technologies for their projects.   The global pharmaceutical industry has grown considerably, due to an ageing population and advances in available treatments. This growth has substantially impacted the pharmaceutical packaging market, which is expected to experience an increase from $135.2 billion in 2023 to $284 billion in 2032,…

Tillotts Pharma (“Tillotts”) marks its 15th anniversary as a member of the Japanese Zeria Group, celebrating a period of growth and collaboration together. The milestone was commemorated in December 2024 with Tillotts’ CEO, Thomas A. Tóth von Kiskér, and members of the leadership team visiting Zeria. During this occasion, Mr. Sachiaki Ibe, chairman of the board of directors and CEO of Zeria Pharmaceutical Co, presented Mr. Tóth a symbolic piece of Japanese art featuring Mount Fuji as a gift to honour Zeria’s appreciation for Tillotts’ accomplishments since the acquisition. Over the past 15 years, Tillotts has consistently achieved strong double-digit…

Following the already completed CEIV Pharma (Center of Excellence for Independent Validators in Pharmaceutical Logistics) certification by IATA (International Air Transport Association) covering air freight for the GEODIS Pharma team in Frankfurt am Main, GEODIS’ ocean freight service in Hamburg has now successfully achieved GDP (Good Distribution Practice) compliance through Bureau Veritas. With the certification, GEODIS is now GDP-compliant throughout Germany. The GDP certification confirms that GEODIS adheres to stringent guidelines and standards that guarantee the safe and seamless transport of pharmaceutical products. This includes temperature control, storage, and handling of medications to ensure their efficacy and safety. In the…

Betacom has announced a partnership with Siemens Industries. The companies have deployed a private 5G network platform at MxD (Manufacturing x Digital), the National Center for Cybersecurity in Manufacturing in Chicago. The platform is the first complete private wireless network to operate behind a Siemens firewall, demonstrating the future of secure enterprise connectivity.  “Manufacturing enterprises need more than just network connectivity – they need a complete solution that seamlessly enables Industry 4.0 applications while maintaining total control of their data and operations,” said Johan Bjorklund, CEO of Betacom. “By partnering with Siemens at MxD, we’re providing manufacturers with a blueprint for digital…

CluePoints, provider of statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards. CluePoints, along with its Research and Development Teams, released three new products in 2024, aiming to transform clinical trial review and leveraging industry-leading software to enhance the interrogation, analysis and presentation of data. Site Profile & Oversight Tool (SPOT) delivers adaptive site monitoring, enabling teams to swiftly pinpoint anomalies and translate insights into strategies and actions. Allowing sponsors and CROs to improve their ability to evaluate the performance of clinical trial sites and adjust site visit…

AMSBIO announces a new range of ready-to-use Human induced Pluripotent Stem Cell (hiPSC) -derived cardiomyocytes, hepatocytes, and neurons. Supplied fully differentiated and available in high-purity formats, these ready-to-use cells help accelerate research by streamlining lab workflows, eliminating the need for in-house differentiation and minimising preparation time. Provided as functionally validated cells, researchers do not need to spend time on in-house validation and can instead apply them directly to their assays without additional steps. This is a major advantage for Contract Research Organisations (CROs) and life science labs who can save time and money on optimisation work. Outstanding batch-to-batch consistency ensures that AMSBIO’s…

Peter Belden, president of Tjoapack US, discusses leading multinational integrations, helping partner companies deliver treatments that address the needs of small patient populations and finding the right balance between personalised solutions and the value offered to clients.  What attracted you to Tjoapack?   Part of the attraction stems from Tjoapack being a family business, an environment I knew very well growing up. My father was a landscape architect, and working for him, I discovered the challenges and opportunities of a family business, which shaped my direction. Landscaping was not my passion, so after studying business and entering the corporate world, I…

PSL (Powder Systems Limited) has enhanced its CakeStand vacuum tray dryer, featuring modular options tailored to the evolving needs of pharmaceutical, biopharmaceutical, and fine chemical manufacturers. Designed to address process inefficiencies, compliance complexities, and scalability challenges, CakeStand provides a flexible and future-proof drying solution. Its advanced design supports laboratories, pilot plants, and full-scale commercial production, ensuring seamless scalability as manufacturing demands grow. As pharmaceutical, biopharmaceutical, and fine chemical manufacturers face increasing regulatory scrutiny, sustainability targets, and the rise of high-potency compounds, CakeStand provides an advanced vacuum tray drying solution designed to address these critical challenges. The next generation of vacuum tray drying has…

Beccy Bell, associate director of Laboratory Services at testing and regulatory consultancy Broughton, outlines the challenges of interpreting the guidance, and measures that can be put into place to ensure pharmaceutical products are compliant with the guidance outlined in several jurisdictions.   Pharmacopeias contain the official standards for the quality of substances in medicines and how to make them. There are four Pharmacopeias: British, European, U.S. and Japanese. While the four sets of standards are largely harmonised, there are nuances that are open to interpretation.  All four Pharmacopeias share the same purpose and goal to ensure that there is quality and…

Infex Therapeutics, an anti-infectives specialist, has announced that in collaboration with Justus-Liebig-University Giessen, it has been awarded a £1 million grant from PACE, to develop a BamA inhibitor targeting multi-drug-resistant (MDR) Gram-negative pathogens. BamA inhibitors are an entirely new class of antimicrobial drug designed to target infections caused by drug-resistant Gram-negative bacteria. BamA is a key novel protein specific to Gram-negative bacteria that was previously considered undruggable. By blocking BamA, these inhibitors weaken the bacteria’s defences, interfere with bacterial growth and make it easier for the body to fight off infection. The grant will allow Infex and JLU to optimise manufacturing processes…

Distilling new insights from a recent podcast with an industry investor from Nordic Capital, ArisGlobal CEO Aman Wasan makes a robust financial case for advanced automation in processing pharma’s multiplying regulatory and safety workloads.  For life science R&D organisations to have a sustainable financial future, those companies must be in a position to maintain or grow profit while minimising the impact of significant and converging market pressures.   Economically and commercially, those pressures range from high interest rates and soaring costs, to increased global supply chain challenges and intensifying competition. Strategically, they also include market-defining changes to the make-up of drug…

Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and biotech industries. This partnership should enable more cost-effective production of therapeutics and facilitate access to the latest biopharmaceutical trends. As part of a strategic partnership, Bürkert Fluid Control Systems has taken a stake in the Giessen-based start-up Green Elephant Biotech. Together with Bürkert, the start-up is aiming to make cell cultivation processes in the pharmaceutical and biotech industries more efficient, flexible and sustainable so that, for…

As breakthrough drug companies look to new geographic markets, including emerging economies to target populations with rare diseases, many are coming up against unforeseen or underestimated barriers. Here, Arriello’s Kate Coleman reviews the findings of new transatlantic research which charts biotechs’ evolving commercialisation strategies and regulatory preparations, and the realities they are experiencing.  The global biotech opportunity was worth an estimated $1.55 trillion worldwide in 2023, and is projected to grow at a compound annual rate of 13.96% between now and 20301. All markets are not equal, however, and the opportunity-cost equation is rarely a constant. To understand the refocusing…

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients. The test identifies the presence or absence of cancerous cells, signs of early and late-stage cancer, whether it is slow or aggressive as well as genetic and hereditary risks in the patient. The new test involves studying the most comprehensive combination of clinically-validated prostate-related biomarkers currently known, in both blood and urine samples. The interpretation of these biomarkers using a proprietary AI-driven algorithm highlights early signs of cancer and characteristic features…

Nigel Winteringham, director, strategic sales, life sciences, EMEA & APAC, Loftware discusses how in today’s business landscape, an organisation’s environmental footprint is something that must be a priority and ignoring the importance can be detrimental. Some life sciences companies, although already on this journey, are understandably concerned with the costs associated with reducing their environmental footprint. However, this doesn’t need to be the case.   While customer demands for ESG conformity rise, organisations are now looking to react and supply their consumer pools with sustainable pledges, which in turn generates pressure for other firms to do the same. For example, AstraZeneca aims to achieve…

L.B. Bohle will showcase a first-of-its-kind truly continuous granulator and dryer at INTERPHEX NYC, 1-3rd April. At Booth 1519A, the company will offer technical overviews of its QbCon1, a three-in-one module providing continuous raw material dosing, twin-screw wet granulation and drying in one compact, mobile machine. The machine’s patented continuous drying process guarantees flow from raw material to dried granulation in a closed, truly continuous operation for improved product quality, increased flexibility and enhanced operator safety.  The QbCon1 can handle throughputs from 0.5-2.5 kilograms per hour (up to 5 kg per hour for certain products), making it suitable for research…

Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer Group and Novo Nordisk’s 2025 Golden Ticket Programme.  The 2025 Golden Ticket Programme was open to early-stage biotech companies focused on novel drug targets and transformational medicines in cardiometabolic diseases, rare blood and rare endocrine disorders, with robust research plans and potential for successful research development.  Following a competitive pitch process reviewed by the Pioneer and Novo Nordisk selection committee, successful applicants were invited to a celebration event held at…

Synexa Life Sciences, a global provider of biomarker and bioanalytical solutions to the pharmaceutical, biotech, and CRO industries, has achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town, South Africa facility. Laboratories play a crucial role in advancing healthcare but are among the most resource-intensive environments in the life sciences industry. Synexa is committed to implementing and enhancing sustainability practices throughout the organisation, without any compromise on quality or scientific excellence. Achieving the My Green Lab Certification at the ‘Green’ level will enable Synexa to further support the increasing customer demand for ethical and…

Antares Vision Group, a technology partner in product and supply chain digitalisation for enterprises and institutions, and a leader in track & trace and quality control systems, has extended its DIAMIND ecosystem of integrated and modular solutions. The company’s new DIAMIND Connect platform manages traceable data and production processes to guarantee end-to-end sustainability, comprehensive traceability and seamless customer engagement for brand owners in a variety of industries with bespoke approaches for each segment.   DIAMIND Connect’s prominent differentiators include modularity – each software module can be adopted separately, independently or in combination with the others, to best manage the production environment and follow…

UPS Healthcare has opened three new specialised cross-docking facilities in Milan, Frankfurt and Mexico City. These facilities provide support for pharmaceutical shipments with a range of time and temperature control requirements.    Next-generation healthcare treatments are driving billions of euros in investment and a heightened demand for precision logistics, with 80% of pharma products in Europe already requiring temperature-controlled transportation. Spanning 28,500m2, the Milan facility has over 20,000 pallet positions capable of storing shipments from 2 to 8°C and 15 to 25°C. Strategically located next to the airport, the facility provides direct movement of shipments to outbound vehicles, bypassing storage and allowing…

Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation. But there’s a big hole in the plan the chancellor outlined in her big growth speech yesterday. Martyn Williams, managing director, COPA-DATA UK discusses how the UK isn’t turning enough of that research into real-world impact.  We excel at discovery, but when it comes to manufacturing, we’re losing out. Groundbreaking science happens here, yet companies too often take their ideas overseas.  There’s a simple reason for that. The UK lacks the facilities, incentives, and policy support to keep manufacturing at home. Without tackling…

Optimal Industrial Technologies has announced the appointment of Sam Henson as its new business development manager for the Americas region. Henson joins the company with a strong academic and technical background, reinforcing Optimal’s commitment to advancing data-driven process control solutions worldwide. With a Ph.D. in pharmaceutics from Duquesne University in Pittsburgh, PA, Sam’s expertise lies in Process Analytical Technology (PAT) applications, particularly in continuous manufacturing. His research in chemometric modelling has helped pioneer lean, cost-effective approaches to data analytics in the pharmaceutical sector. Now at Optimal, Henson aims to leverage his experience to position the company as a leader in…

Donald Trump is back, and he is already creating commotion. Yogan Patel, head of life science at MHA discusses what this means for life sciences. The weeks since his inauguration have been dominated by unrelenting coverage of fights and fireworks with allies, enemies and everyone in between. The world is watching Trump and waiting for his latest wave of radical policy changes.   This is especially true in the life science sector. Trump and his new health and human services secretary, Robert F Kennedy Jnr, have expressed concerns about “big pharma” and vaccinations, causing alarm within the industry.   As ever with…

After the pharmaceutical industry’s muted mergers and acquisitions (M&A) landscape in 2024—deal count remained flat while deal value was down 41% year-over-year—Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025.   A large part of that expectation is fuelled in part by upcoming patent expirations and the subsequent need to accelerate innovation. For pharma businesses with an eye on growth or expansion, a reinvigorated dealmaking environment could bring a wave of opportunities—but making the most of them will require leaders to think beyond the deal itself.   Even the most advantageous transaction can be…

Uniphar is expanding its international presence with the launch of three new facilities located in Raleigh, USA, Lelystad, Netherlands, and Dublin, Ireland.  With 57 years’ industry experience, Uniphar’s new facilities position the company to support pharmaceutical and biotech companies more effectively, offering comprehensive solutions that cover the entire product lifecycle. The new locations aim to ensure the timely delivery of critical therapies to patients worldwide, whilst supporting pharmaceutical companies to navigate complex market access challenges, from clinical trials to global product launches.  The Raleigh, North Carolina facility, covering 65,000 sq. ft., is a GMP & GDP pharma-grade storage facility designed to handle ambient,…

LogiPharma, is embedding environmentally responsible practices across every part of the event, from its agenda to operations. Key highlights include: One key aspect is LogiPharma’s collaboration with One Tree Planted. Through this partnership, LogiPharma will offset the carbon emissions from groups of five or more primary delegates by investing in climate projects based on the emissions caused by air travel to the event. Central to the sustainability theme is the Sustainability Zone, a dedicated stage that will focus on actionable solutions. The agenda also features a series of keynotes and panel discussions addressing real-world sustainability challenges. Top sustainability-focused speakers…

Front Line Medical Technologies has announced the UK launch of its CE-marked COBRA-OS. The COBRA-OS has received approval for sale in the United Kingdom based on its CE mark under MDR as a Class III medical device. This milestone enables Front Line to bring its innovative technology to a market that has consistently led the way in pre-hospital REBOA implementation. The UK’s pioneering role in REBOA began in 2018 when London’s Air Ambulance performed the world’s first pre-hospital REBOA procedure, demonstrating the potential for this life-saving intervention beyond hospital walls. “The United Kingdom represents a crucial milestone in our mission to advance aortic occlusion…

Recipharm, a leading global contract development and manufacturing organisation (CDMO), has announced that a new modular sterile filling system specifically tailored for process development, pilot scale and clinical supply, is now fully operational at its state-of-the-art facility in Wasserburg, Germany. This advanced system performs aseptic filling within a Grade A isolator and operates in full compliance with GMP standards.  The system offers unmatched flexibility, featuring interchangeable modules that support various product types, such as syringes and vials. An additional pre-filled syringe (PFS) module is being added to the installation, broadening the system’s capabilities and cementing its position as a versatile…

Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) invites industry professionals to find new business partners, showcase equipment and services to potential customers, as well as enjoy networking and celebrate the 5th anniversary. The Congress takes place in Berlin, Germany, on 14-15th April 2025.  PHARMAP is a networking event organised by BGS Group that annually unites over 350 key players of the pharmaceutical sector. Among regular participants are executives of pharmaceutical companies, service and equipment providers, CMOs and CDMOs, supply chain and procurement experts. From the beginning, PHARMAP has welcomed over 1000 delegates from more than 600 companies and held over 1000…